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Abbreviations
2-APB 2-aminoethoxydiphenyl borate
ABC ATP binding cassette
CARC inverted CRAC sequence
CFP cyan fluorescent protein
CHO chinese hamster ovary
CLSM confocal laser scanning microscopy
CRAC cholesterol recognition amino acid consensus
DRG dorsal root ganglion
EGF epidermal growth factor
FAST DiO 3,3-dilinoleyloxacarbocyanine perchlorate
FRAP fluorescence redistribution after photobleaching
HaCaT human adult low calcium high temperature
HEK293 human embryonic kidney
HEKmTRPV3 HEK293 cells stably expressing mouse TRPV3
MbCD methyl-b-cyclodextrin
NBD-PC 1-palmitoyl-2-(6-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]caproyl)-sn-glycero-3-
phosphocholine
PDZ PSD-95, Dlg1, and zo-1 (this domain was first monitored in these proteins)
PTEN phosphatase and tensin homologue
Q10 temperature coefficient corresponding to a 10°C temperature increase
SHIP Src homology 2-containing inositol 5’ phosphatase
TIR total internal reflection
TRP transient receptor potential
TRPA ankyrin-rich transient receptor potential
TRPC canonical transient receptor potential
TRPM melastatin transient receptor potential
TRPMP mucolipidin transient receptor potential
TRPP polycystin transient receptor potential
TRPV vanilloid transient receptor potential
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Introduction
1.1 Cholesterol
Biological membranes surround cells and eukaryotic cell organelles, confer protection, and aid in
controlling nutrient supply as well as cellular communication. Cellular membranes consist of a highly
fluid bilayer and are composed of different lipids, which incorporate various proteins. A prominent
component of animal cells is cholesterol, which was first identified in the 18th century by Poulletier
de la Salle as a part of gallstones.
The structure of cholesterol is unique among membrane components (Fig. 1 A) [1,2]. It exhibits a
small polar hydroxyl group, which faces the headgroups of adjacent phospholipids in bilayers, and a
larger hydrophobic moiety, consisting of a bulky and stiff polycyclic structure and a flexible isooctyl
hydrocarbon chain. One side of the flat ring system, known as b face, bears methyl groups, and the
opposed smooth side is referred to as a face. Featuring an octanol:water partition coefficient (logP)
of 7.11, cholesterol is poorly soluble in water and readily partitions into lipid membranes.
1.1.1 Functions and distribution of cholesterol
The cholesterol content varies among different cell types and organelles [1,2]. Within cells, the highest
concentration of cholesterol is found in the plasma membrane (up to 50 mol%), followed by the en-
docytic pathway with the Golgi apparatus and the endoplasmic reticulum. Mitochondrial membranes
contain vanishingly low amounts of cholesterol. Due to its small hydrophilic group, cholesterol is
able to easily switch between the two membrane leaflets (flip-flop).
With regards to plasma membranes, it has been postulated that several membrane components
organise themselves into microdomains that contain distinct lipids and proteins [3]. Lipid domains
enriched in cholesterol and sphingolipids are called lipid rafts. Their existence, size and stability
have been in discussion for a long time due to limitations of analytical methods that allow a direct
examination of these domains in living cells. However, advances in microscopic and spectroscopic
techniques have shed some light on the existence of fluctuating rafts in plasma membranes under
physiological conditions [3].
Cholesterol participates in a plethora of physiological processes. Aside from its role as a precursor
of compounds like steroid hormones and bile salts, cholesterol is also required for different vesicular
transport mechanisms. Cholesterol affects the order of acyl chains of adjacent lipids and thereby
modulates the physical properties of biological membranes, such as membrane fluidity and thick-
ness [1,2]. In artificial membranes, it has been shown that cholesterol either loosens or tightens bio-
logical membranes, depending on the arrangement and saturation of neighbouring acyl side chains.
In cell membranes, it mainly enhances membrane rigidity and reduces the fluidity as well as the
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Figure 1: Structure and properties of cholesterol; A Structure of cholesterol. Hydrophilic (red)
and hydrophobic (blue) moieties of the molecule are encircled. Stick models represent a frontal
view from the b side and a side view. B Possible mechanisms of cholesterol-dependent regulation
of protein functions. Cholesterol-rich domains can recruit signalling proteins into spatially confined
signalling platforms (1). Regions of distinct cholesterol content may influence protein functions by
providing different physical environments characterised by determined membrane thickness (2) or
fluidity (3), thus, enabling tilted protein arrangements or protein movements. Cholesterol molecules
can directly interact with hydrophobic motifs in some proteins (4).
permeability. The fact that cholesterol prevents temperature-dependent membrane phase transitions
is of particular importance in living cells [1,2].
Cholesterol can initiate and modulate signal transduction processes via direct and indirect mech-
anisms. Certain proteins can accumulate in lipid rafts, which function as signalling platforms or
hubs (Fig. 1 B1+2). Due to an increased spatial proximity of interacting partners, this condition can
augment the velocity and robustness of signalling events. In contrast, the separation of molecular
players in raft and non-raft regions can terminate or prevent signalling events. Cholesterol affects the
physical properties of the plasma membrane (Fig. 1 B2+3) and, thus, may influence the available
room for conformational mobility. Furthermore, cholesterol can regulate signal pathways by directly
interacting with membrane proteins (Fig. 1 B4). Meanwhile, different cholesterol recognition do-
mains have been identified, such as CRAC (cholesterol recognition amino acid consensus) and CARC
(inverted CRAC sequence) motifs or tilted peptides [4], that facilitate cholesterol:protein interactions.
1.1.2 Some aspects of cholesterol homoeostasis and transport
In vertebrates, cholesterol is essential to maintain normal cell functions. Most of the required choles-
terol can be synthesised de novo, and only a small fraction needs to be absorbed from the diet. All
mammalian cells are able to synthesise cholesterol, but the production rates strongly vary among
different cell types. The majority of de novo-synthesised cholesterol derives from the liver, but many
other organs also produce cholesterol in considerable amounts, e.g. the intestines, adrenal glands,
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reproductive organs, and epidermis.
Since cholesterol is hydrophobic, it is transported in the circulatory system within various lipopro-
teins. These are complex particles that contain apolipoproteins, phospholipids, cholesterol, choles-
terol esters, and free fatty acids. Lipoproteins are classified according to their density, composition,
and function. Cells can exchange single components with lipoproteins or absorb them entirely via
receptor-mediated endocytosis. Intracellularly, cholesterol is transported via vesicles or sterol car-
rier proteins [5]. In order to export cholesterol from cells and to regulate the cholesterol content of
the plasma membrane, cells express cholesterol transporters, including two members of the ABC
(ATP-binding cassette) transporter family, namely ABCA1 and ABCG1 [6].
1.2 Structure and function of the integument
The skin, as the outer physical barrier of humans and many other species, has to perform a multitude
of tasks to facilitate survival. First of all, it protects the organism from harmful environmental
influences, like mechanical forces, toxic substances, UV radiation, and pathogens. Furthermore,
the skin is an important element of the innate immune system, and the respective functions are
mediated by specific immune cells in the skin. Skin glands that secrete sweat or sebum aid in
maintaining an adequate body temperature and cover the skin with a protective, antiseptic film that
avoids dehydration. Sensory modalities that are implemented in the skin include hot, warm and cold
temperature sensation, tactile force detection, and mechanical pain sensation.
The skin is composed of three layers (Fig. 2 A): the epidermis, dermis, and subcutis. The epidermis
is the outermost layer of the skin and consists of a stratified squamous epithelium without blood
vessels (detailed information in section 1.2.1 and [7,8]). A basal membrane separates the epidermis
from the subjacent dermis.
The dermis consists of two layers of connective tissue with lymphatic and blood vessels, different
nerve endings, skin glands, and hair follicles. The region adjacent to the epidermis, the papillary
layer, contains loose connective tissue with a high water content and, thus, maintains the skin
turgor. It forms small protrusions into the epidermis, the so-called dermal papillae, which strengthen
the connection of epidermis and dermis. The reticular layer is located subjacent to the papillary
layer. Its dense network of irregularly arranged collagenous and elastic fibres confers tear strength
and elasticity of the skin.
The inner layer of the skin is the subcutis and covers muscles, tendons, and bones. Anatomically, the
subcutis does not belong to the skin, but it forms an inseparable functional unit with the epidermis
and dermis. The subcutis consists of loose connective tissue with many adipocytes. Hence, it serves
mostly as a heat shield and energy reservoir. Similar to the dermis, lymphatic and blood vessels,
mechanoreceptors and some hair follicle roots are located in the subcutaneous tissue.
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Figure 2: Structure of the skin and detailed scheme of the epidermis; A Three-layered or-
ganisation of the skin with skin appendages like hairs, sebaceous and sweat glands. B Schematic
representation of the epidermis. Several keratin isoforms and involucrin are marker proteins of dif-
ferent stages of differentiation. Thus, they enable the distinction of the epidermal layers. For clarity,
the illustration of other cell types like melanocytes or Langerhans cells has been omitted.
1.2.1 Structure of the epidermis
The major task of the epidermis is the formation of a protective barrier. Its predominant cell type
is the keratinocyte, which accounts for over 90% of the cells in the epidermis. The epidermis can
be morphologically and functionally divided into four distinct layers, which represent diverse levels of
differentiation of keratinocytes (Fig. 2 B) [7,8]. These differentiation levels are characterised by the
expression of specific proteins, such as distinct isoforms of keratin and integrins.
The innermost epidermal cell layer is the stratum basale. Keratinocytes in the stratum basale bear a
strong proliferation potential and are considered epidermal stem cells. They form a cell monolayer that
is attached to the basal membrane by hemidesmosomes. After several cell divisions, the keratinocytes
initiate a complex differentiation programme and migrate actively towards the skin surface. In
addition, melanocytes are located between the keratinocytes of the stratum basale. They produce and
secrete melanins, which are absorbed by surrounding keratinocytes and participate in the protection
from UV radiation.
In the adjacent epidermal layer, the stratum spinosum, keratinocytes are connected via desmosomes
and they start to produce lamellar bodies (Odland bodies), which contain different lipids and proteins
like hydrolytic enzymes. In this layer, Langerhans cells, specialised dendritic cells that resemble
macrophages in morphology and function, mediate the initial recognition of antigens and thereby
10
Structure and function of the integument
contribute to the defence of the organism against pathogens.
On the apical side of the stratum spinosum, the stratum granulosum follows. The keratinocytes
of this region adopt a flatter shape and produce keratohyalin granules, which contain precursors of
proteins required for the aggregation and crosslinking of keratins. On the upper side of the stratum
granulosum, the keratinocytes secrete the Odland bodies. Thereby, the extracellular space is enriched
with different lipids [9,10] that, together with hydrophobic, crosslinked keratins, aid in establishing the
skin’s water impermeability. Furthermore, hydrolytic enzymes are released that later on promote the
correct shedding (desquamation) of the uppermost cornified cells.
The keratinocytes of the upper stratum granulosum undergo apoptosis, dehydrate, and their or-
ganelles, including the nucleus, disintegrate. The remaining, still cohesive layer of cornified kera-
tinocyte ghosts is embedded in a dense environment formed by lipids and proteins and is referred
to as stratum corneum. These cell remnants are called corneocytes and mainly consist of different
crosslinked structure proteins like keratins. Depending on the mechanical demands on the skin, the
thickness of the stratum corneum varies. In humans, the development of keratinocytes from prolif-
erating cells to fully cornified cells takes about two weeks. The corneocytes remain in the stratum
corneum for another two weeks. Afterwards, desquamation, the final superficial shedding from the
skin, takes place. In healthy individuals, the proliferation of keratinocytes in the stratum basale and
the desquamation of corneocytes from the stratum corneum are well-balanced processes in order to
maintain a even thickness of the cutis.
1.2.2 Regulation of keratinocyte differentiation
The homoeostasis of the epidermis requires a strictly regulated balance between factors that pro-
mote keratinocyte proliferation and factors that favour these cells’ differentiation. A plethora of
stimuli affect keratinocyte physiology, including growth factors, intercellular contacts, or tempera-
ture changes [11,12]. One of the most prominent substances influencing keratinocyte differentiation
is calcium [7,8,12]. In the stratum basale, the extracellular calcium concentration is low; it gradually
increases towards the apical layers of the epidermis and reaches its highest concentration in the stra-
tum granulosum. It is not yet fully understood how keratinocytes recognise the extracellular total
or ionised calcium concentration. The G protein-coupled Ca2+-sensing receptor seems to play an
important role in this process [12], but is most likely supported by other sensors, such as transient
receptor potential channels (TRP) [12,13].
Some lipid factors, e.g. ceramides, sphingolipids, the lipid-like vitamin D3 and vitamin A, have
been shown to influence keratinocyte physiology [14]. Steroids like cholesterol and its derivative
cholesterol sulfate have also been demonstrated to play important roles in inducing or regulating the
differentiation process [9]. It has been observed that an inhibition of the cholesterol synthesis as well
as a depletion of cholesterol counteract the differentiation of keratinocytes [15], whilst a cholesterol
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enrichment facilitates this process. In this context, it has been shown that cholesterol enhances
the formation of cornified envelopes, a protein-lipid layer that replaces the plasma membrane of
corneocytes [16].
A dysregulation of epidermal growth can lead to chronic skin diseases, such as psoriasis vulgaris, a
non-infectious, inflammatory dermatological disorder that is characterised by an accelerated turnover
of keratinocytes [17]. In affected individuals, keratinocytes cross the epidermis about four times faster
than in healthy people. This results in an enhanced fraction of partially differentiated keratinocytes
at the skin surface and an impaired barrier function. In case of atopic dermatitis, a disease with an
increasing prevalence in developed countries, patients exhibit keratinocyte proliferation and differen-
tiation defects [18]. The pathogenesis of this disease is poorly understood, but results obtained so far
indicate the participation of keratinocytes and immune cells. Further diseases are also associated with
changes of the proliferation capacity of keratinocytes. Such may be due to altered signalling cascades
that sustain an increased cell proliferation and promote the development of skin cancers like basal
cell and squamous cell carcinoma [19]. These are indeed the most common forms of non-melanoma
skin tumours in the elderly.
1.2.3 Migration of keratinocytes
Keratinocytes move either in a three-dimensional direction during physiological turnover or as flat
sheets during the reepithelialisation phase of wound healing [20,21]. In various respects, sheet migra-
tion resembles the movement of individual cells, including cytoskeletal reorientations or chemotactic
guidance. However, in case of sheet migration, additional factors such as cell junctions mediate cell-
superordinated behaviours that influence the initiation, maintenance and direction of keratinocyte
movement. Similarly, migration is also affected by chemokines, growth factors and electrical signals.
During sheet migration, planar cell polarity can be observed: keratinocytes at the leading edge of the
cell assembly, the so-called ”leading cells”, adopt a polarised shape [20,21]. Towards the leading edge,
these cells extend lamellipodia. At the same time, the connection to those cells following is maintained
throughout the whole process. The polarised morphology of migrating cells is accompanied by an
asymmetric front-to-back distribution of signalling proteins and lipids. The most prominent example
for a lipid gradient is that of phosphatidylinositol(3,4,5)-trisphosphate. This gradient results from
distinct distribution patterns of activated phosphoinositide 3-kinases and the phosphatases SHIP and
PTEN [22]. With respect to cholesterol, migrating endothelial cells display a front-to-back viscosity
gradient in their plasma membranes [23], which has been attributed to a polarised distribution of
cholesterol. Diverse studies addressed the polarity of lipid rafts in migrating cells (summarised by
Man˜es [24]), but results obtained so far are highly contradictory. This is probably due to variations
in cell models and experimental approaches used, as well as due to the existence of distinct kinds
of lipid rafts with altering compositions. Conflicting data has also been reported with regard to
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the influence of cholesterol on cell migration. Depletion of cholesterol decreases the migration of
different cell types [23,25–29], but on the other hand, cholesterol enrichment may also effectively inhibit
cell migration, as has been demonstrated in macrophages [30,31] and T cells [32].
1.3 TRP channels
The family of transient receptor potential (TRP) channels consists of 28 mammalian genes that
encode cation channel subunits [33]. TRP channels are expressed in virtually all cell types, contribute
to sensory perception and decode environmental signals of versatile nature. Hence, TRP channels
play crucial roles in a broad spectrum of cellular and physiological processes.
A functional TRP channel is assembled of four subunits [33], each containing six transmembrane-
spanning segments and intracellularly located N- and C-termini (Fig. 3 A). It has been proposed that
the fifth and sixth membrane segments in combination with their connecting loop form the centrally
located channel pore, which bears the selectivity filter and channel gate(s). Based on sequence
homology, the family of mammalian TRP channels can be divided into six subfamilies: the canonical
(TRPC), vanilloid (TRPV), melastatin (TRPM), mucolipidin (TRPMP), polycystin (TRPP), and
ankyrin-rich (TRPA) TRP channels.
1.3.1 Structure and biophysical characteristics of TRPV3
TRPV3 belongs to the vanilloid branch of TRP channels, a subfamily that has first been defined
when TRPV1, a heat-stimulated channel that is also activated by vanilloid compounds like capsaicin,
has been described. Among the TRPV channels, TRPV1 to TRPV4 are heat-activated, non-selective
cation channels, whereas TRPV5 and TRPV6 are transcriptionally regulated, Ca2+-selective chan-
nels, which contribute to the vitamin D3-controlled Ca2+ homeostasis. In some TRPV channels,
alternative splicing or unconventional translation initiation can further increase the complexity of
functional channels. In TRPV3, three different splice variants have been observed [34], but doubts
remain whether these translate into functional variations. At their intracellular N- and C-termini,
TRPV3 channels bear conserved domains and motifs, such as ankyrin repeats, the TRP domain,
several putative phosphorylation sites, and a PDZ recognition site [34–36].
TRPV3 is a moderately Ca2+-selective cation channel. TRPV3-mediated currents exhibit outwardly
rectifying current-voltage relations with reversal potentials close to 0 mV [34–37]. During prolonged
activation, TRPV3 channels are being stabilised in the open pore conformation, and the current-
voltage relation adopts a more linear shape [38]. Accordingly, TRPV3 signals exhibits a characteristic
sensitisation following repetitive activation [35,36,39], a feature that distinguishes TRPV3 from other
TRP channels. Sensitisation results in boosted signals and occurs independently of the kind of
13
TRP channels
Figure 3: Structure and regulation of TRPV3 channels; A Structure of a single TRP channel
subunit with six membrane-spanning helical segments (S1-S6) and intracellular N- and C-termini. A
recursive loop between S5 and S6 dips into the plasma membrane and features the selectivity filter.
B Schematic representation of some factors regulating TRPV3 channel activity, including exogenous
modulators, such as 2-APB or camphor, and endogenous modulators, like the membrane potential,
carbohydrate pyrophosphates, unsaturated fatty acids, or protons.
stimulus.
1.3.2 Expression profile and functions of TRPV3
TRPV3 has been discovered by three independent laboratories in 2002 [34–36], and has been charac-
terised as a cation channel that is activated by innocuous warm temperatures. A few years later,
TRPV3 knockout mice revealed a defective temperature recognition [40]. Thus, TRPV3 belongs to
the group of the so-called thermoTRPs, which comprises several members of different TRP subfami-
lies. However, further studies demonstrated no obvious alterations in thermal preference behaviour of
TRPV3 knockout mice [41]. This indicates that the development of a temperature sensing dysfunction
probably depends on the genetic background of the animals or on compensatory mechanisms that
are triggered by a lack of TRPV3 expression.
TRPV3 is predominantly localised on the plasma membrane of keratinocytes in the basal and
suprabasal epidermal layers [35,36]. It has also been detected in keratinocyte-derived cell lines, such
as the HaCaT (human adult low calcium high temperature) [42] cell line [43,44]. Further sites of ex-
pression of TRPV3 have been found in other tissues, including cells of the oral cavity and nose [45,46],
embryonic stem cells [47], some brain tissues [48] and sensory neurons of dorsal root ganglia (DRG) in
humans and primates [34,35].
To date, various physiological and pathophysiologial functions have been suggested for TRPV3.
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These range from hot temperature perception, nociception and inflammatory hyperalgesia [49,50], to
hair growth [13,51]. In addition, it seems that TRPV3 is directly involved in the formation and main-
tenance of the epidermal barrier. Cheng et al. demonstrated that TRPV3 forms a signalling complex
with the epidermal growth factor receptor and, thus, probably regulates keratinocyte differentiation
processes [13]. This conclusion is supported by the fact that TRPV3 knockout mice display anomalies
regarding the formation of the epidermal barrier [13]. Consistent with these findings, temperatures
that activate TRPV3 accelerate the epidermal barrier recovery after mechanical skin disruption [52].
Moreover, the activation of TRPV3 results in an elevated nitric oxide production [53], and this molecule
plays a key role in wound healing processes [54]. Novel results indicate TRPV3 to be associated with
cell cycle and differentiation regulation of several cell types [46,47,51,55,56].
Consequently, it has been evaluated whether TRPV3 is involved in the pathogenesis of skin dis-
eases [57]. Indeed, an increased TRPV3 expression has been observed in dermal cells of patients suf-
fering from rosacea [58]. It is noteworthy that mice bearing a mutated, constitutively active TRPV3
variant display symptoms that resemble those observed in patients suffering from atopic dermati-
tis, e.g. pruritus, inflammation, and hyperkeratosis [59–62]. In humans, various constitutively active
mutations of TRPV3 are associated with the Olmsted syndrome [63], the only established hereditary
channelopathy involving TRPV3. Olmsted syndrome is a rare skin disease accompanied by severe
pruritus and hyperkeratosis due to enhanced keratinocyte turnover and apoptosis.
1.3.3 Regulation of TRPV3 channel activity
Like many other TRP channels, TRPV3 is influenced by a multitude of different factors (reviewed
by Nilius [37], Fig. 3 B), some of which are introduced in the following section. As mentioned above,
TRPV3 is temperature-sensitive and responds to warm temperatures, with thresholds ranging between
32°C and 39°C. Similar to the majority of temperature-regulated TRP channels, TRPV3 exhibits an
intrinsic voltage dependence. In the absence of physical or chemical activators, voltage-induced
channel gating is only achieved at unphysiologically positive voltages. Upon exposure to chemical
activators or temperature changes, the threshold for voltage-dependent channel gating shifts towards
more negative, physiological membrane potentials [64,65], thereby allowing the channels to open in
response to the respective stimuli.
Like TRPV1, TRPV3 can alternatively be activated by heat or by non-thermal stimuli. 2-APB (2-
aminoethoxydiphenyl borate) has been the first identified chemical activator of TRPV3 [66]. Since
2-APB modulates members of almost all TRP subfamilies in a positive or negative way [67], its action
on TRPV3 is non-specific. Subsequently, camphor has been shown to activate TRPV3 [40]. Other
TRPV3 stimulators have been recognised later on, with many of them being herbal ingredients, e.g.
carvacrol, eugenol, and thymol, which share the terpene structure of camphor [45]. Other modulators
of TRPV3 are lipids. Unsaturated fatty acids, like arachidonic acid, are considered endogenous reg-
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ulators of TRPV3 activity [68]. They directly potentiate TRPV3 currents evoked by stimulation with
2-APB, but fail to activate these channels alone. In contrast farnesyl pyrophosphate, an intermedi-
ate of the mevalonate pathway, directly activates TRPV3, and may be involved in TRPV3-mediated
nociception [49].
On the other hand, lipid modulators of TRPV3 may also inhibit channel activity, as is the case
of farnesyl pyrophosphate, a precursor of isopentenyl pyrophosphate [69]. Resolvin D1 [70], an anti-
inflammatory agent produced by the cyclooxygenase 2 pathway, and phosphatidylinositol 4,5-bisphos-
phate [71] also attenuate TRPV3 channel activity. Moreover, the divalent cations Ca2+ and Mg2+ are
among the negative regulators of TRPV3 [39,72], a feature that is displayed by several TRP channels.
Furthermore, the TRPM8 activator icilin [44] and the unspecific TRP channel blocker ruthenium red
inhibit TRPV3 channel activity [34–36]. In the last years, some more selective TRPV3 antagonists have
been described [57], but their pharmacodynamic or pharmacokinetic properties impeded any further
development towards a possible therapeutic application.
1.3.4 Cholesterol-dependent regulation of temperature-mediated TRPs
The local cholesterol content of biological membranes strongly influences the signalling properties of
numerous ion channels and other transmembrane proteins. In this context, the effect of cholesterol
on the activity of TRP channels has been intensely studied. Concerning TRPV1, published results
indicate a stimulus- or cell-type-dependent modulation of the channel’s activity [73]. On the one side,
in TRPV1-transfected HEK293 (human embryonic kidney) cells, cholesterol enrichment decreases
the susceptibility of TRPV1 to hot temperatures by raising its activation threshold [74]. On the other
hand, cholesterol extraction reduced channel activity during prolonged activation of TRPV1 in CHO
cells expressing this channel [75]. By contrast, other reports found no significant changes of TRPV1
activity upon cholesterol depletion [74]. Accordingly, different ideas have been put forward to explain
the cholesterol-dependent modulation of TRPV1. Liu et al. observed a reduced plasma membrane
fraction of TRPV1 in cholesterol-depleted DRG neurons [76]. The group of Rosenbaum identified
a cholesterol-binding motif in rat and human TRPV1 that may be responsible for a cholesterol-
dependent inhibition of TRPV1 activity [77].
Regarding the cholesterol dependence of the cold receptor TRPM8, channel activity increased upon
cholesterol depletion, which was possibly induced by the translocation of TRPM8 from rafts to non-
raft regions [78]. A changed glycosylation pattern of TRPM8 may be the trigger of this channel’s
lipid raft segregation. The heat-activated channel TRPM3 is inhibited by cholesterol enrichment,
whereas it is directly activated by pregnenolone sulphate, a cholesterol-derived steroid hormone [79].
Concerning TRPV3, findings regarding the cholesterol dependence of this ion channel have not yet
been published.
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Although cholesterol is an essential substance for the water-impermeability of the epidermis, little
is known about the function of cholesterol with regards to keratinocyte migration. Since this lipid
strongly determines the physical properties of biological membranes, we examined the microviscosity
and the distribution of cholesterol in the plasma membrane of migrating keratinocytes. For this pur-
pose, we performed fluorescence redistribution after photobleaching (FRAP) and fluorescence lifetime
measurements combined with illumination under total internal reflection (TIR) conditions. For our
experiments, we used HaCaT keratinocytes since this cell line is known to adopt a polarised mor-
phology with extended lamellipodia, a feature resembling migrating keratinocytes. In addition, we
monitored local plasma membrane cholesterol concentrations with filipin, a cholesterol-binding fluo-
rophore. To address the question how the cholesterol transporters ABCA1 and ABCG1 influence the
plasma membrane’s microviscosity, we deactivated these transporters using pharmacological inhibitors
or specifically knocked down their expression applying a small interference RNA-based approach. To
quantify the migration capacity of HaCaT cells, we carried out a wound healing-resembling scratch
assay with subsequent analysis by means of automated multiwell time-lapse microscopy.
The pivotal roles of calcium and cholesterol in the decision-making programme of terminal kera-
tinocyte differentiation and the prominent TRPV3 expression in these cells prompted us to research
whether the activity of TRPV3 may be regulated by cholesterol. Consequently, we investigated the
effects of cholesterol on TRPV3 channel signalling with fluorometric Ca2+ influx measurements and
electrophysiological patch clamp experiments. We focused on the response of recombinantly ex-
pressed or native TRPV3 in keratinocytes to heat and to chemical activators. Temperature threshold
changes of TRPV3 activation induced by a modified plasma membrane’s cholesterol content were
monitored. Results from this study are expected to contribute to the understanding of the role of
TRPV3 in the calcium- and cholesterol-dependent terminal differentiation and apoptosis induction
of keratinocytes.
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Keratinocyte migration plays an important role in cutaneous wound healing by supporting the
process of reepithelialisation. During directional migration cells develop a polarised shape with
an asymmetric distribution of a variety of signalling molecules in their plasma membrane. Here,
we investigated front-to-back differences of the physical properties of the plasma membrane of
migrating keratinocyte-like HaCaT cells. Using FRAP and fluorescence lifetime analysis, both
under TIR illumination, we demonstrate a reduced viscosity of the plasma membrane in the
lamellipodia of migrating HaCaT cells compared with the cell rears. This asymmetry is most likely
caused by a reduced cholesterol content of the lamellipodia as demonstrated by filipin staining.
siRNA-mediated silencing of the cholesterol transporter ABCA1, which is known to redistribute
cholesterol from rafts to non-raft regions, as well as pharmacological inhibition of this transporter
with glibenclamide, strongly diminished the viscosity gradient of the plasma membrane. In addi-
tion, HaCaT cell migration was inhibited by glibenclamide treatment. These data suggest a prefer-
ential role of non-raft cholesterol in the establishment of the asymmetric plasma membrane
viscosity.
© 2012 Elsevier Inc. All rights reserved.
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Introduction
Cell migration contributes to a multitude of physiological as well
as pathophysiological processes, including development, wound
healing, inflammation, and tumour dissemination. To migrate
directionally, cells develop a polarised shape accompanied by cy-
toskeletal reorientation and a polarised redistribution of signalling
proteins and lipids in the plasma membrane. The most prominent
example in lipid polarisation is the lateral asymmetric distribution
of PIP3, which is generated by the interplay between locally acti-
vated PI3K and PTEN or SHIP-1 in Dictyostelium or neutrophils, re-
spectively [1]. The role of other lipid components or physical
membrane properties on cell migration is less well understood.
Furthermore, there are very few investigations analysing the over-
all physical membrane properties of migrating cells which are
highly influenced by the lipid composition. Ghosh et al. examined
the viscosity of the plasma membrane of migrating endothelial
cells [2], eliciting a slightly enhanced migration by stiffening the
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membrane with α-tocopherol and an inhibited migration by re-
ducing the microviscosity upon lyso-lipid incorporation. In a fol-
low up publication, this group showed that these cells reveal a
front-to-back gradient of plasma membrane microviscosity with
an enhanced viscosity at the front of the migrating endothelial
cells using FRAP and fluorescence polarisation experiments [3].
Cholesterol strongly influences the physical membrane proper-
ties [4]. The cholesterol content of the plasma membrane of a cell
is regulated by the cellular cholesterol biosynthesis as well as its
uptake from and release to serum lipoproteins. Release of choles-
terol to serum lipoproteins is facilitated by the plasma membrane
cholesterol transporters ABCA1 and ABCG1, which presumably
mediate a transversal, ATP-dependent transport of cholesterol
from the inner to the outer membrane leaflet [5]. Expression of
functional ABCA1 was shown to alter the fluidity of plasma mem-
branes [6]. Furthermore, studies using cholesterol-enriched mac-
rophages, which play a role in atherosclerosis, show not only
that functional ABCA1 inhibits migration of these macrophages
due to an enhanced fraction of cholesterol in their plasma mem-
brane [7], but also that deletion of ABCA1 and ABCG1 leads to an
inhibited macrophage mobility [5].
Cutaneous wound healing depends on the recruitment of fibro-
blasts, endothelial cells, and keratinocytes [8], the migration of the
latter determines the process of reepithelialisation [9]. Keratino-
cytes typically migrate in cell assemblies, and cells at the edge
form pronounced lamellipodia. Among other factors, keratinocyte
migration is stimulated by activation of the EGF receptor [10].
Here, using FRAP and fluorescence lifetime measurements under
total internal reflection (TIR) illumination, we show that migrat-
ing keratinocyte-like HaCaT cells exhibit a polarised cholesterol
distribution when stimulated with EGF, leading to a reduced
microviscosity of their lamellipodia compared to the cell rears.
Pharmacological inhibition of the cholesterol transporter ABCA1,
which is expressed in HaCaT cells [11], diminished cell migration
tested by a scratch assay and reduced the microviscosity gradient
in polarised HaCaT cells. In addition, after silencing ABCA1 with
siRNA, no plasma membrane microviscosity gradient was observ-
able in polarised HaCaT keratinocytes.
Materials and methods
Cell culture
The spontaneously immortalised, untransformed human keratino-
cyte cell line HaCaT was kindly provided by Dr. U. Anderegg (De-
partment of Dermatology, University of Leipzig, Germany). The
cells were maintained in Dulbecco's modified Eagles medium
with 1 g/l glucose, supplemented with 10% (v/v) foetal calf
serum (FCS), 1% glutamine, 100 U/ml penicillin, and 100 μg/ml
streptomycin (all PAA Laboratories, Pasching, Austria) and cul-
tured at 37 °C in an atmosphere of 5% CO2. For passaging, cells
were washed, incubated for 10 min with PBS supplemented with
0.8 mM EDTA at 37 °C and trypsinised. For measurements, cells
were seeded onto glass coverslips in 35-mm cell culture dishes.
Transfection of HaCaT cells
HaCaT cells were transiently transfected with Lipofectamine 2000
(Invitrogen). For cotransfection, siRNA and plasmid DNA transfection
solutions were prepared separately in OptiMEM (Invitrogen) with
500 ng DNA and 25 pmol siRNA per 1.5 μl Lipofectamine 2000. The
final concentration of siRNA against ABCA1 or ABCG1 (Supplementa-
ry Table 2, stealth siRNA, containing 3 different sequences at equal
portions, Invitrogen) was 25 nM siRNA and 500 ng/ml plasmid
DNA. After transfection of HaCaT cells, we usedmedia devoid of anti-
biotics to enhance cell viability; however we observed no change in
transfection efficiency in the presence or absence of FCS in culture
medium.
Fluorescence redistribution after photobleaching measurements
under TIR illumination (TIR/FRAP)
The fluorescence redistribution after photobleaching (FRAP) ex-
periments were done 1 day after seeding, when no additional ac-
tivation of the cells was performed. To investigate the effect of
defined concentrations of the human epidermal growth factor
(EGF, Sigma-Aldrich), cells were cultured under serum-free condi-
tions for 24 h followed by the addition of EGF and, optionally, in-
hibitors of different ABC transporters (Sigma-Aldrich), or DMSO
as control for further 12–15 h. HaCaT cells were stained with
2.5 ng/ml of the plasma membrane probe FAST DiO (carbocyanine
with diunsaturated Δ9,12-C18 alkyl substituents, Invitrogen) dilut-
ed in HEPES-buffered solution (HBS) containing 134 mM NaCl,
6 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 5.5 mM glucose, 10 mM
HEPES (pH 7.4) and 0.2% (w/v) bovine serum albumin for
20 min at room temperature (RT). After washing with HBS, cells
at the edge of larger cell assemblies were examined. A sketch
and a detailed explanation of the used setup for FRAP measure-
ments using TIR excitation can be found in a previous publication
[12]. For imaging of FAST DiO-stained HaCaT cells, we used the at-
tenuated 488 nm line of an Ar+ laser (Lasos, Jena, Germany) se-
lected by an AOTF (AA Opto-Electronic, Orsay Cedex, France). A
514 nm beamsplitter (Chroma, Rockingham, VT) allowed for the
separation of excitation and emission, and the emission light was
filtered by a 514 nm RazorEdge longpass filter (Semrock, Roches-
ter, NY). The 514 nm line was employed for bleaching of a
diffraction-limited spot in the plasmamembrane of the cells. Images
were acquired using an EMCCD camera (iXon DV887, Andor, Belfast,
UK) controlled by the TILLvisION software (TILL Photonics, Gräfel-
fing, Germany). One FRAP cycle consisted of 16 prebleach images,
acquired every 20 ms, followed by a 5-ms lasting spot bleaching
and immediate acquisition of 20 images in 20-ms intervals. This pro-
tocol was 10 times repeated every 10 s. After background correction
of the images, the diffusion coefficient was approximated by a
convolution-based algorithm as described previously [13].
For FRAP measurements with siRNA-mediated knockdown of
ABC transporters in HaCaT cells, we cotransfected HaCaT cells
with appropriate siRNA constructs and with a plasmid coding for
an RFP-labelled nuclear protein to identify the transfected cells
or with the plasmid encoding the nuclear RFP alone for control
measurements. Due to its locally restricted cellular expression,
the nuclear RFP did not influence the TIR/FRAP measurements
and additionally possessed spectral properties that could be suffi-
ciently separated from those of DiO (excitation of the RFP oc-
curred with the 488 nm line of the Ar+ laser and emission was
filtered with a 685/40 nm bandpass filter). Seven hours after
transfection, HaCaT cells were starved for 4 h, followed by an incu-
bation of 12–15 h in 10 ng/ml EGF-containing, serum-free cell cul-
ture medium prior to FRAP measurements.
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Fluorescence lifetime measurements under TIR illumination
For fluorescence lifetime measurements, HaCaT cells were
seeded onto glass coverslips and labelled with NBD-PC (1-
palmitoyl-palmitoyl-2-(6-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)amino]caproyl)-sn-glycero-3-phosphocholine, a phosphatidylcholine
carrying an NBD group on one acyl chain, Invitrogen). NBD-PC
was dissolved in chloroform, evaporated under a stream of nitrogen
and resuspended to a final concentration of 4 μM in HBS. Cells were
stained for 20 min at RT, washed with HBS and measured. For fluo-
rescence lifetime measurements, we used the previously described
TIRF microscope [12], which was upgraded by a 470 nm picosecond
pulsed diode laser (LDH-D-C-470, PicoQuant, Berlin, Germany). Ex-
citation light was cleaned by a Z463/25 X-HT filter (Chroma) and
coupled into the excitation path instead of the Ar+ laser. For NBD
excitation, the pulse frequency was set to 20 MHz. An aperture in
the excitation pathway enabled the selective measurement of
distinct areas of the cells by constricting the excitation spot. The
emission light was filtered by a 488 nm RazorEdge longpass filter
(488-RU, Semrock), split by polarisation and directed onto two
photomultiplier tubes (PMT). Data were recorded by the TimeHarp
software (PicoQuant), using time-correlated single photon counting
(TCSPC) at a rate of 105 counts/s until reaching 104 counts in the
peak of the histogram. The instrument response function (IRF)
was recorded using an empty coverslip to enable reconvolution of
the TCSPC data. The fluorescence decay of NBD was approximated
on a triexponential function [14] using an anisotropy model and
reconvolving the measured IRF by the FluoFit Pro software
(PicoQuant).
Confocal laser scanning microscopy-based fluorescence lifetime
measurements
Confocal laser scanning microscopy (CLSM)-based fluorescence
lifetime imaging (FLIM) of NBD-PC-labelled HaCaT was performed
as described previously [14]. Cells were stained with NBD-PC as
described above. Images were acquired by an inverted CLSM
(Fluoview 1000, Olympus, Tokyo, Japan) equipped with a FLIM
upgrade kit (PicoQuant) using a 60×/1.35 oil-immersion objec-
tive. NBD was excited with a 470 nm pulsed diode laser at a
pulse frequency of 10 MHz. Emission was filtered using a 540/
40 nm bandpass filter and recorded by a single-photon avalanche
photodiode. About 100 frames of 512×512 pixels were acquired
and summed up. The IRF was recorded using a clean coverslip
and no emission filter. FLIM data analysis was performed with
the SymPhoTime software (PicoQuant) using a triexponential
model function, and reconvolving it with the IRF. Prior to FLIM
analysis, the values of the two short lifetimes τ1 and τ2 were esti-
mated from the whole image by summing up all pixel histograms.
To calculate the average lifetimes of the FLIM image, the original
image was binned 4× to a final size of 128×128 pixels. Again,
the triexponential decay model function was reconvolved with
the IRF and fitted with short lifetimes τ1 and τ2 (calculated as de-
scribed above) fixed, while the environment-dependent long life-
time τ3 was freely varied for each individual pixel.
Confocal laser scanning microscopy and filipin staining of HaCaT
The cholesterol content of the plasma membrane of HaCaT cells
was visualised by staining with filipin (Sigma-Aldrich) [15], a
known cholesterol marker. The plasma membrane was counter-
stained with different commercially available plasma membrane
probes, i.e. FAST DiO (20 min, 2.5 ng/ml, RT) or DiI (20 min,
2.5 ng/ml, 37 °C, carbocyanine with saturated C18 alkyl substitu-
ents, Invitrogen) in HBS. After washing the cells with PBS, cells
were fixed with 3% paraformaldehyde (PFA) in PBS for 20 min at
RT, washed and incubated with 50 μg/ml filipin in PBS for 2 h at
RT. Cells were observed using an inverted confocal laser scanning
microscope (LSM 510Meta, Carl Zeiss AG, Oberkochen, Germany),
with a C-Apochromat 40×/1.2 water immersion objective. For
monitoring FAST DiO, we used the 488 nm line (Ar+ laser) for ex-
citation, a UV/488 beamsplitter and a 505 nm longpass filter. For
visualising the DiI, we used the 543 nm laser line (He–Ne laser),
a UV/488/543/633 beamsplitter and a 560 nm longpass emission
filter. Excitation of filipin occurred with the 364 nm line (Enter-
prise UV laser), and we used a 385 nm longpass emission filter.
Image analysis was performed with ImageJ (US National Institutes
of Health, Bethesda, MD) [16].
Scratch wound healing assay
For wound healing assays 2⋅105 HaCaT cells per well were seeded
into 24-well plates. After 1 day, medium was exchanged and after
2 days, confluently grown cells were starved for 4 h in culture me-
dium without FCS and supplemented with 5 μg/ml mitomycin C
(AppliChem GmbH, Darmstadt, Germany) to inhibit cell prolifera-
tion [17]. Afterwards an artificial wound was caused by scratching
the cell monolayer with a 200-μl pipette tip. Transmission images
of the cells on the scratch were recorded with a 5× objective using
a cooled CCD camera (SensiCam, PCO AG, Kehlheim, Germany).
Cells were incubated with various agents diluted in serum-free
medium under cell culture conditions for 12–24 h. Additional im-
ages were recorded at the same locations at various time points
using an automated microscope with a motorised stage (Axio
Observer.Z1, Zeiss). The microscope and the image acquisition
were controlled by the Micro-Manager 1.3 software (US National
Institutes of Health) [18]. The wound healing was quantified,
using ImageJ, by measuring the width of the cell-free scratch,
which allowed to calculate the distance the cells migrated.
Results
Polarised HaCaT cells exhibit a plasma membrane viscosity gradient
To analyse the plasmamembrane viscosity, we performed FRAP ex-
periments in polarised HaCaT cells using a commercially available
plasmamembrane dye and analysing its distribution under TIR exci-
tation [12].We chose FASTDiO as fluorophore,which shows a bright
plasma membrane staining in HaCaT cells, and analysed single cells
at the edge of larger cell assemblies, which resemble border cells at
the edge of a wound. These cells formed lamellipodia and their rears
contacted other cells. On the lamellipodia of HaCaT cells, grown in
culture medium containing FCS but without further growth factors,
we found a mean diffusion coefficient of 1.30±0.06 μm2/s of FAST
DiO, which was slightly but statistically significantly higher than
that at the cell rears (1.21±0.07 μm2/s, Fig. 1a). This plasma mem-
brane viscosity gradient was found in about 83% of the analysed
cells. A gradient in the plasma membrane properties was also de-
tectable using fluorescence lifetime measurements of NBD-PC-
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labelled HaCaT cells under TIR illumination. NBD exhibits three fluo-
rescence lifetimes, of which the longest lifetime τ3 (about 6–14 ns in
different cell types) strongly depends on the physicochemical prop-
erties of the environment of the fluorophore. The two shorter life-
times of about 0.2–0.5 ns and 2–3 ns are relatively independent of
the environment [14] and were, therefore, not considered for the
analysis of the viscosity gradient (Supplementary Fig. 1). The long
fluorescence lifetimes of NBD at the cell fronts of HaCaT (8.49±
0.10 ns) were statistically significantly lower than at the cell rears
(8.70±0.14 ns) (Fig. 1b). Similar results were obtained in spatially
resolved fluorescence lifetime images of NBD-PC-stained HaCaT
cells (Fig. 1c). Slower diffusion of membranemarkers as well as lon-
ger fluorescence lifetimes of NBD indicate a higher membrane vis-
cosity at the cell rears.
Viscosity differences are related to altered membrane cholesterol
contents
The membrane cholesterol content strongly influences the mem-
brane properties [4]. It is therefore possible that the microviscosity
gradient is caused by a heterogeneous distribution of cholesterol in
the plasma membrane of polarised HaCaT cells. To further investi-
gate this hypothesis, we stained polarised HaCaT cells with filipin
that binds specifically to cholesterol [15], and visualised the cells
by confocal microscopy. Thin membrane structures that are stacked
like filipodia and lamellipodia may not be resolved in the z-axis by
CLSM, leading to an apparent increase in fluorescence intensity, be-
cause the sum of fluorescence intensities of twomembrane layers is
recorded [19]. Therefore, we counterstained the cells with the lipo-
philic plasma membrane markers DiI or FAST DiO as reference
(Fig. 2). The recorded fluorescence intensity of filipin was related
to that of the plasma membrane markers, revealing a lower choles-
terol content at the lamellipodia compared with the cell bodies of
polarised HaCaT cells. These data suggest that a heterogeneous cho-
lesterol concentration contributes to the viscosity gradient of the
plasma membrane found in migrating HaCaT cells.
Activation of HaCaT cells promotes the development of a plasma
membrane viscosity gradient
Keratinocyte migration is known to be enhanced in the presence
of growth factors that bind to the EGF receptor [10]. Thus, we
wanted to elucidate the impact of EGF on the observed microvisc-
osity gradient. To eliminate the influence of growth factors con-
tained in the FCS, we kept HaCaT cells in serum-free medium for
24 h, and subsequently added defined concentrations of EGF for
about 12 h. Scratch experiments with HaCaT cells revealed highest
migration rates at concentrations of 10 ng/ml EGF (Fig. 3a) and a
decreasing migration rate at higher EGF concentrations, consistent
with literature data [10]. Interestingly, HaCaT cells activated with
Fig. 1 – Migrating HaCaT cells reveal an asymmetric plasma membrane viscosity. a: HaCaT cells were cultured under normal cell
culture conditions in FCS-containing medium, and stained with the plasma membrane marker FAST DiO 1 day after seeding.
a: Diffusion coefficients at the lamellipodia and rears of spontaneously polarised cells at the border of large cell assemblies were
determined with TIRF-based FRAP experiments. b: Fluorescence lifetime τ3 measured at the fronts and rears of NBD-PC-stained
HaCaT cells under TIR excitation. c: Space-resolved fluorescence lifetime image of a NBD-PC-stained HaCaT cell. The DIC image (left)
and the corresponding pseudocoloured photon-weighted image of averaged fluorescence lifetimes (right) are shown. Average
lifetime values of the depicted regions of interest are for ROI1 τ=7.4 ns and ROI2 τ=8.6 ns. Profiles of averaged fluorescence
lifetimes of NBD-PC indicated by white lines are illustrated in the adjacent diagram. Scale bar: 20 μm. (a and b each with n=18
from at least 3 independent experiments; mean±SEM, single measurements are depicted in grey; paired Student's t-test *p<0.05.)
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10 ng/ml EGF also developed the most significant viscosity gradi-
ent determined by the FRAP approach (1.23±0.04 μm2/s and
1.10±0.04 μm2/s at the fronts and the rears, respectively,
Fig. 3b). Starvation of HaCaT cells led to a reduction of the viscosity
gradient in the plasma membrane compared with EGF-treated
cells (Fig. 3) or cells grown in culture medium containing FCS
(Fig. 1). When cells were treated with higher EGF concentrations
(100 ng/ml), in vitrowound healing was impaired, and the viscos-
ity gradient was again not statistically significant (p=0.08, 1.15±
0.06 versus 1.04±0.05 μm2/s at the cell fronts and backs, respec-
tively) and only detectable in 65% of the cells. We observed an
overall increase in microviscosity by stimulating HaCaT cells
with EGF. In the presence of 100 ng/ml EGF, diffusion coefficients
decreased by 17% and 24% at the cell fronts and rears, respectively,
when compared with serum-starved cells. In agreement with
these data, EGF treatment increased the cellular cholesterol con-
tent by over 40% (Supplementary Fig. 2).
In HaCaT cells that were not located at the border of an assembly
but following the leaders, we did not observe amicroviscosity gradi-
ent (Supplementary Fig. 3). These cells also did not adopt such a pro-
nounced polarised morphology with lamellipodia like the leaders.
ABCA1 influences the membrane viscosity gradient
The plasma membrane cholesterol content and domain formation
may be influenced by specialised proteins. To investigate the influ-
ence of cholesterol transporters of the ABC transporter protein
family, we pharmacologically inhibited ABCA1 by glibenclamide
[20] and analysed the cell migration and the microviscosity gradi-
ent. Scratch assays revealed that glibenclamide reduced HaCaT cell
migration in response to 10 ng/ml EGF (Fig. 4a). We noted that at
higher concentrations of glibenclamide (400 μM) the number of
polarised HaCaT cells is reduced and staining with FAST DiO was
less efficient. For FRAP measurements we reduced the glibencla-
mide concentration to values that allowed the cells to form a
polarised shape. HaCaT cells treated with 200 μM glibenclamide
still appeared polarised but the microviscosity gradient in the
presence of EGF was abolished (Fig. 4b). Inhibition of other choles-
terol transporters ABCG1 or ABCB1 with 20 μM benzamil [21] or
verapamil [22], respectively, did not significantly influence the ob-
served plasma membrane viscosity gradient (Supplementary Fig.
4). Since glibenclamide is a relative poorly specific inhibitor of dif-
ferent ABC transporters, we verified the influence of ABCA1 on the
microviscosity gradient by siRNA-assisted knockdown in FRAP ex-
periments. We proved the knockdown of mRNAwith reverse tran-
scription–polymerase chain reaction. In our hands, the mRNA of
ABCA1 and ABCG1 was most efficiently downregulated after 24 h
using 25 nM siRNA (Supplementary Fig. 5). Consistent with the
pharmacological inhibition of ABCA1, HaCaT cells treated with
siRNA against ABCA1 exhibited randomly distributed viscosity
gradients, whereas cells with silenced ABCG1 still possessed uni-
former plasma membrane viscosity gradients with a higher diffu-
sion at their lamellipodia compared with their rears (Fig. 5).
Discussion
Cell migration is a highly regulated and complex process. It in-
volves large rearrangements of the plasma membrane, which are
mediated in part by interaction with cytoskeletal proteins and
Fig. 2 – Cholesterol staining of polarised HaCaT cells. HaCaT cells were seeded in culture medium, counterstained with the plasma
membranemarkers FAST DiO or DiI, fixed, stainedwith filipin and imaged by CLSM. Representative images of spontaneously polarised
HaCaT cells are shownwith transmission light acquisition (left column), fluorescence image of the plasmamembranemarker (middle
left column), and filipin fluorescence (middle right column). The right panel shows pseudocoloured images of the ratio of the intensity
images of filipin and the corresponding plasmamembranemarkers (high cholesterol content is indicated in red, low cholesterol content
in blue). Scale bar: 20 μm. Filled arrow heads: plasma membrane regions without lamellipodia, empty arrow heads: lamellipodia.
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the asymmetric accumulation of adhesive structures. We investi-
gated the migration of the spontaneously immortalised, untrans-
formed keratinocyte cell line HaCaT that is often used as a cell
model to study keratinocyte movements and to simulate wound
healing [10,23]. Different signalling proteins, like chemoattrac-
tants, receptors or further signal transduction proteins, as well as
lipids are involved in the migration process and partly show an
asymmetric front-to-back distribution in the plasma membranes
of these cells. Cholesterol makes up a large fraction of plasma
membrane components [4] that greatly influence the physical
properties of membranes; hence we were interested in its influ-
ence on keratinocyte migration. Many studies addressed the dis-
tribution of rafts, small cholesterol- and sphingomyelin-rich lipid
domains, in migrating cells, although sometimes leading to incon-
sistent conclusions, probably due to different cell models, experi-
mental approaches, and different kinds of lipid rafts with
altering compositions [24]. Studies modifying the cellular choles-
terol content indicate that the plasma membrane cholesterol
plays an important role in cell migration. Cholesterol depletion de-
creases migration of different cell types [3,25–27]. Intriguingly,
enrichment of cholesterol can also inhibit effective cell migration,
as demonstrated for macrophages [28] and T cells [29]. It is argued
that both methods destroy plasma membrane rafts, leading,
amongst others, to a disturbed signalling of the small GTPases
RhoA and Rac1 [25,28].
Up to now, there are only few studies addressing the plasma
membrane properties of migrating keratinocytes. Thus, we inves-
tigated the plasma membrane lipid composition of polarised
keratinocyte-like HaCaT cells. The plasma membrane at the lamel-
lipodia on the cells fronts revealed a higher fluidity compared with
the cells rears. The lateral asymmetry of plasmamembrane viscos-
ity was consistently detected using different fluorescence tech-
niques on living HaCaT cells, including FRAP and fluorescence
lifetime measurements of an environment-sensitive plasma mem-
brane marker. These methods are independent of the fluorescence
intensity, and are, thus, less prone to staining irregularities. The
additional application of TIR illumination enabled a relative selec-
tive plasma membrane excitation [30]. Fluorescence lifetimes of
NBD in a similar range to that reported here have been measured
previously [14]. The diffusion coefficients of FAST DiO of about
1.0–1.5 μm2/s measured by our approach are also similar to previ-
ously published data measured for dialkylcarbocyanines in fish
keratocytes [31].
Since it is known that cholesterol can influence the viscosity of
biomembranes, we visualised cholesterol in fixed HaCaT cells with
filipin. We related the filipin staining to the distribution of differ-
ent plasma membrane markers, revealing a lower cholesterol con-
tent at the lamellipodia compared with the cells rears. We
conclude that cholesterol contributes to the difference in plasma
membrane viscosity of polarised HaCaT.
HaCaT cells required activation, for example with EGF, a known
stimulator of keratinocyte migration, to stably form a microviscos-
ity gradient. They developed the most pronounced viscosity gradi-
ents at an EGF concentration, which also elicited the strongest
response in migration, as quantified by scratch wound healing as-
says. Moreover, at this EGF concentration, a gradient with lower
a
10 ng/ml 100 ng/ml1 ng/ml0 ng/ml
EGFs
he
et
 m
ig
ra
tio
n 
ve
lo
cit
y 
(µm
/h)
12
10
0
6
8
4
2
#
##
##
front rear
**
D
(µm
/s
)
2
2.0
1.5
1.0
0.0
0.5
10 ng/ml 100 ng/ml1 ng/ml0 ng/ml
front rear
EGF
front rear front rear
b
#
## ##
## ##
Fig. 3 – Uponactivationwith EGF,HaCaT cells are stimulated tomigrate anddevelop a front-to-back asymmetry of their plasmamembrane
viscosity. a:HaCaT cellmigration indifferent concentrationsof EGFwasmeasuredusing awoundhealing assay.Migrationwasquantified at
minimal 12 hafter scratchingbydetermining thedistance, the cellsmigrated into the scratchedarea (n=6). b:HaCaTwere seeded, starved,
and incubated for 12–15 h with different concentrations of EGF. After staining with FAST DiO, diffusion coefficients were determined by
TIR/FRAP experiments at the cells fronts and rears (n=30 from at least 4 independent experiments). (a and b: mean±SEM, paired
Student's t-test **p<0.008; unpaired Student's t-test #p<0.05, ##p<0.008 compared with corresponding values in the absence of EGF.)
814 E X P E R I M E N T A L C E L L R E S E A R C H 3 1 8 ( 2 0 1 2 ) 8 0 9 – 8 1 8
Klein et al. 2012
23
viscosity at the leading edge was found in about 80% of the inves-
tigated cells, whereas in the absence of EGF and other serum-
derived growth factors, we could not detect a viscosity gradient.
The minority of EGF-treated cells that did not display a lower vis-
cosity at the leading edge might represent cells that appeared
polarised to the investigator but are probably non-migrating. Ad-
ditionally, EGF enhanced the overall membrane viscosity of
HaCaT cells, which is in agreement with a higher cholesterol con-
tent in EGF-treated cells that we confirmed by determining the
cellular cholesterol content. The reason for this cholesterol in-
crease is probably an EGF-induced gain in cholesterol synthesis
reported previously [32]. Similarly, Ghosh et al. detected a growth
factor-induced increase in plasma membrane microviscosity of
endothelial cells [2,3]. However, by the same group (Vasanji et
al.), it was shown that endothelial cells exhibit a higher viscosity
at their cell fronts compared with their rears [3]. The authors
also detected an enhanced cholesterol accumulation at the cells
front visualised by labelling the cells with NBD-cholesterol.
This apparent discrepancy with our data may be caused by sev-
eral factors. Firstly, Vasanji et al. used endothelial cells, measured
by FRAP of the DiI-C16 with saturated alkyl substituents and fluo-
rescence anisotropy of TMA-DPH. Our study addressed keratino-
cyte migration investigated mainly with FRAP using FAST DiO
under TIR illumination. Using TIRF, the axial excitation depth is
about 100–150 nm, leading to an excitation of the ventral plasma
membrane that is adherent to the coverslip and parts of the adja-
cent cytosol. Since we analysed only the ventral plasma mem-
brane, this fact or the use of different membrane dyes that
possibly prefer different membrane regions may account for
some discrepancies with other studies. Secondly, Vasanji et al.
used NBD-labelled cholesterol to investigate the front-to-back
cholesterol distribution. This analogue exhibits an up-side-down
orientation in the membrane and, therefore, is not well suited to
represent the endogenous cholesterol distribution [33]. Thirdly,
cholesterol can change the viscosity of biomembranes in different
manners, depending on other components of the membrane and
there are hints that cholesterol might even reduce the viscosity
of the plasma membrane of aortic endothelial cells [34]. Thus, an
increase rather than a reduction of the microviscosity in the lamel-
lipodia of endothelial cells compared to keratinocytes might also
be attributed to a generally different composition and cholesterol
content of the plasmamembrane in these cells. Another possibility
is that migrating cells rather require a distinct local viscosity or
cholesterol content at certain parts of their plasma membrane,
e.g. at the lamellipodium, than the formation of a viscosity gradi-
ent. Fourthly, the development and direction of plasmamembrane
microviscosity gradients might be cell type-specific. Indeed, other
studies found no differences in the plasma membrane viscosity of
migrating neutrophils [35], which is consistent with our results
on migrating differentiated HL-60 cells, in which we could not de-
tect plasma membrane viscosity gradients (data not shown).
Weisswange et al. also found no differences in the diffusion coef-
ficient of a dialkylcarbocyanine dye of migrating fish keratocytes
between the leading and the trailing edges [31]. Moreover, these
authors observed a diffusion barrier at the leading edge by label-
ling the cells at the top and examining the spreading of the dye
to the bottom of the cells, indicating a faster diffusion at the trail-
ing edge. Their data apparently contradict our results, but the dif-
ferent cellular systems might not be comparable. Moreover, the
detected diffusion barrier might be caused by a dense, locally re-
stricted protein arrangement, as discussed by these authors, and
probably does not represent general plasma membrane viscosity
at the leading edge.
Whereas some cell types, e.g. immune cells, move as single
cells, processes associated with wound closure usually involve
sheet migration [36]. We investigated polarised HaCaT keratino-
cytes in front of sheets and found a microviscosity gradient in
their ventral cell membrane. In following HaCaT cells within the
cell assembly, which did not adopt a pronounced polarised mor-
phology, we detected a more uniform microviscosity. Other stud-
ies addressed for example single cell movement, and found no
gradient or a viscosity gradient inverse to the observed membrane
viscosity in HaCaT cells. Thus, the establishment of a viscosity gra-
dient might also be a feature of the different forms of individual or
collective cell movement.
Fig. 4 – Pharmacological inhibition of ABCA1 reduces HaCaT
cell migration and impedes on the microviscosity gradient. a:
Quantification of HaCaT migration stimulated with 10 ng/ml
EGF in the presence of different concentrations of
glibenclamide determined by scratch assays (n=6, scale bar:
250 μm). b: Diffusion coefficients of polarised HaCaT cells
incubated with 10 ng/ml EGF or 200 μM glibenclamide and
10 ng/ml EGF extracted from TIR/FRAP experiments of FAST
DiO-stained cells (n>30). (a and b:mean±SEM, paired Student's
t-test **p<0.008; unpaired Student's t-test #p<0.05.)
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It is an open question how migrating cells establish and main-
tain a microviscosity gradient. One possibility is that specific pro-
teins are responsible for the formation of the viscosity gradient
by locally regulating the plasma membrane cholesterol content.
Therefore, we focussed on a cholesterol transporter of the ABC
family, ABCA1, whose main function is to facilitate the cholesterol
export to ApoA-I. Previous studies indicating that ABCA1 can affect
the physical properties of its membrane environment support the
hypothesis that this transport protein is involved in the establish-
ment of a plasma membrane viscosity gradient [6]. In addition to a
decreased cell migration, pharmacological inhibition of ABCA1
also diminished differences between the viscosity at the fronts
and rears of HaCaT cells in the presence of EGF. These data support
an important role of cholesterol in the establishment of the micro-
viscosity gradient in migrating keratinocytes. Inhibition of ABCG1,
another ABC transporter that is known to be involved in cholester-
ol transport, with benzamil did not significantly alter the plasma
membrane viscosity gradient and inhibited cell migration to a
lesser extent than glibenclamide treatment (data not shown).
We cannot completely exclude that the observed effects of the
pharmacological inhibitors might involve other mechanisms as
glibenclamide is known to inhibit several different ABC trans-
porters. It is commonly used as antidiabetic drug, since it blocks
ABCC8 at low concentrations, which is not expressed in HaCaT
cells [11], however. At higher concentrations, glibenclamide also
blocks ABCB1 (MDR1), ABCC9 (SUR2), ABCC7 (CFTR) in addition
to ABCA1 [37–39]. Whereas ABCC9 and ABCC7 are transporters
for small ions, ABCB1 is indeed also a cholesterol transporter,
though its main function is the exclusion of a variety of amphipha-
tic substrates from cells [40]. However, inhibiting ABCB1 with ve-
rapamil, a known MDR inhibitor [22], did not diminish the
observed microviscosity gradient in polarised HaCaT cells.
Furthermore, the specific involvement of ABCA1, but not
ABCG1, in the gradient formation was confirmed by an siRNA ap-
proach. The mechanisms by which these ABC transporters medi-
ate cholesterol efflux seem to be not identical. Whereas ABCA1 is
thought to promote an accumulation of cholesterol outside of
detergent-resistant membrane patches [41], ABCG1 probably
operates preferentially within lipid rafts [42]. Our data are, thus,
consistent with a redistribution of cholesterol from the raft to
the non-raft phase by ABCA1.
Future investigations should decipher the molecular mecha-
nisms by which the microviscosity gradient influences cell motili-
ty. One possible mechanism is an altered activity of small G
proteins like Rac1 at the cell fronts and rears. Recently it was dem-
onstrated that ABCA1 and ABCG1 activities influence the activa-
tion of Rac1 in macrophages [5,7]. Alternatively, an established
microviscosity gradient might be important for the interaction of
the cytoskeleton with the plasma membrane, and efficient actin
polymerisation at the leading edge might require a defined micro-
viscosity [3].
It is also conceivable that different cholesterol concentrations
at the leading and trailing edges have a direct effect on keratino-
cyte migration, and that the observed effects on plasma mem-
brane microviscosity are secondary. A direct influence of
cholesterol on cell migration may be due to the interaction of cho-
lesterol with certain proteins that are important for cell migration
and that may require a defined cholesterol concentration to oper-
ate efficiently. For instance, cholesterol depletion is known to alter
the organisation of the actin cytoskeleton [43]. The membrane-
cytoskeleton adhesion was recently demonstrated to be strength-
ened upon cholesterol depletion [44]. Similarly, it is established
that cholesterol depletion of plasma membranes promotes the
spontaneous activity of EGF receptors and increases the HB-EGF
release [45,46].
Conclusions
Thus, we demonstrated that migrating keratinocytes establish a
cholesterol gradient leading to a lower microviscosity at the lead-
ing edge of these cells. This gradient can be diminished by siRNA-
mediated silencing or pharmacologically inhibiting ABCA1, which
also dramatically reduces the ability of keratinocytes to migrate.
Fig. 5 – siRNA-mediated silencing of ABCA1 but not of ABCG1, results in a random distribution of microviscosity gradients in HaCaT
cells. HaCaT cells were transfected with siRNA against ABCA1 (middle panel) or ABCG1 (right panel) and a nuclear-located
RFP-coding plasmid or with the plasmid alone (control, left panel). Twenty-four hours after transfection and 12 h after addition of
10 ng/ml EGF, we determined the diffusion at the fronts and rears of HaCaT cells at the edge of large cell assemblies under TIR
illumination (n=31; mean±SEM; paired Student's t-test **p<0.008, *p<0.05).
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We conclude that the establishment and maintenance of a lateral
cholesterol asymmetry is important for wound healing and is at
least partly mediated by the activity of ABCA1 in keratinocytes.
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TRPV3,  a  thermosensitive  cation  channel,  is predominantly  expressed  in keratinocytes.  It contributes  to
physiological  processes  such  as  thermosensation,  nociception,  and  skin  development.  TRPV3  is poly-
modally  regulated  by chemical  agonists,  innocuous  heat,  intracellular  acidification  or  by membrane
depolarization.  By manipulating  the  content  of  plasma  membrane  cholesterol,  a key  modulator  of the
physicochemical  properties  of  biological  membranes,  we  here addressed  the  question,  how the  lipid  envi-
ronment  influences  TRPV3.  Cholesterol  supplementation  robustly  potentiated  TRPV3  channel  activity  by
sensitising  it  to  lower  concentrations  of  chemical  activators.  In  addition,  the  thermal  activation  of  TRPV3  is
significantly  shifted  to lower  temperatures  in  cholesterol-enriched  cells.  The  sensitising  effect  of  choles-
terol was  not  caused  by an  increased  plasma  membrane  targeting  of the channel.  In  HaCaT  keratinocytes,
which  natively  express  TRPV3,  a cholesterol-mediated  sensitisation  of  TRPV3-like  responses  was  repro-
duced.  The  cholesterol-dependent  modulation  of TRPV3  activity  may  provide  a molecular  mechanism  to
interpret  its  involvement  in keratinocyte  differentiation.
© 2013  Elsevier  Ltd. All  rights  reserved.
1. Introduction
The epidermis, as the interface between an individual and its
environment, has to perform different essential functions. It pro-
tects an organism against harmful external influences, pathogens,
and dehydration. Keratinocytes are the major cell type of the
epidermis and bear responsible for the formation of an outer bar-
rier, the stratum corneum. To generate this barrier, keratinocytes
undergo a complex differentiation programme that terminates in
apoptosis and cornification [1]. Differentiation is accompanied by
synthesis of several structural proteins and lipids, like ceramides,
fatty acids and cholesterol. To prevent skin barrier dysfunction, the
proliferation and differentiation of keratinocytes needs to be tightly
regulated. Multiple factors are known to influence the balance
between keratinocyte proliferation and differentiation, including
growth factors, extracellular calcium concentrations, cell den-
sity, or lipids like ceramides, cholesterol and cholesterol-derived
metabolites.
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Another function of keratinocytes, together with neurons that
extend into the epidermis, is to recognise environmental factors,
some of which are decoded by members of the transient recep-
tor potential (TRP) family of cation channels. For instance, TRPV3,
a member of the vanilloid subfamily, is predominantly expressed
in keratinocytes of all epidermal layers [2,3]. Its activity is poly-
modally regulated by chemical and physical queues. TRPV3 can
be activated by numerous, poorly selective compounds like 2-
aminoethoxydiphenyl borate (2-APB) [4], and by secondary plant
metabolites, such as camphor [5], carvacrol, eugenol and thymol
[6]. TRPV3 is activated by temperatures above 33 ◦C [2,3,7]. The ini-
tial characterisation of TRPV3-deficient mice indicated that TRPV3
participates in heat perception [5], but more recent data demon-
strate that this effect strongly depends on the genetic background
of the investigated animals [8]. In addition, cytosolic acidification
[9], membrane potential [3], and various lipid factors [10–13] are
known to influence TRPV3 activity. Apart from thermosensation,
TRPV3 is discussed to be involved in physiological and patho-
physiological processes, including nociception [14,15], hair growth
[16], inflammation [10], and skin diseases [17–19]. Recent find-
ings demonstrated that the epidermal barrier in TRPV3−/− mice is
defective [16], pointing to a role of TRPV3 in regulating keratinocyte
differentiation and cornification. Since former studies have demon-
strated that cholesterol also plays an important role in keratinocyte
physiology we wondered about the influence of cholesterol on
TRPV3 signalling.
0143-4160/$ – see front matter © 2013 Elsevier Ltd. All rights reserved.
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In the present study, we introduce cholesterol as a new regula-
tor of TRPV3 channel activity. We  modified the cholesterol content
of HEK293 cells stably expressing mouse TRPV3 and performed
calcium and whole-cell patch clamp analyses. These experiments
revealed that cholesterol enrichment robustly potentiates TRPV3
by shifting its sensitivity to lower activator concentrations and by
sensitising TRPV3 to lower temperatures. The influence of choles-
terol on TRPV3 activity was not restricted to the recombinant
expression model, but also observed in HaCaT keratinocytes, which
endogenously express TRPV3 [20,21], and are widely used to study
keratinocyte physiology [22].
2. Methods
2.1. Cell culture and transfections
HEK293 cells were maintained in Earle’s minimum essential
medium (MEM), supplemented with 10% foetal calf serum (FCS,
v/v), 2 mM l-glutamine, 100 units/ml penicillin, and 100 g/ml
streptomycin (all PAA Laboratories, Pasching, Austria). To obtain
a HEK293 cell line stably expressing mouse TRPV3 (HEKmTRPV3),
cells were transfected with a pcDNA3.1 plasmid encoding a C-
terminally CFP-tagged mTRPV3. All transfections were performed
with a Fugene HD lipofection reagent (Promega, Madison, USA),
according to the manufacturer’s instructions. Individual clones
were picked under optical control in an epifluorescence micro-
scope, reseeded in serial dilutions, and grown in culture medium
supplemented with 1 mg/ml  G418. After clonal selection and ini-
tial expansion, the established HEKmTRPV3 cell line was  grown in
medium containing 0.4 mg/ml  G418.
The spontaneously immortalised, untransformed human ker-
atinocyte cell line HaCaT (human adult low calcium high
temperature) was  cultured in Dulbecco’s modified Eagle’s medium
(DMEM) with 1 g/l glucose, supplemented with 10% FCS, 2 mM l-
glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin.
After reaching a density of about 70%, HaCaT cells were washed
and incubated for 10 min  in PBS supplemented with 0.8 mM EDTA
at 37 ◦C, harvested by mild trypsinisation, and reseeded. All cells
were grown at 37 ◦C in a humidified atmosphere with 5% CO2.
2.2. Cholesterol modification
Modification of the cellular cholesterol content was achieved
using methyl--cyclodextrin (MCD). MCD is known to extract
cholesterol from living cells or, when preloaded with cholesterol, to
enrich cells with cholesterol [23]. To generate MCD–cholesterol
complexes, cholesterol (Sigma–Aldrich) was dissolved in ethanol
(20 mg/ml), heated and added to a MCD-containing solution
(200 mM in PBS, Sigma–Aldrich). We  used saturated mixtures with
a molar ratio of MCD:cholesterol of 10:1 [23]. Unless other-
wise stated, cholesterol depletion or enrichment was  performed
by incubating the cells for 15 min  at 37 ◦C in HEPES-buffered
solution (HBS) containing 134 mM NaCl, 6 mM KCl, 1 mM MgCl2,
1 mM CaCl2, 5.5 mM glucose and 10 mM HEPES (pH 7.4, adjusted
with NaOH), and supplemented with 10 mM MCD or 2.5 mM
MCD–cholesterol, respectively. These conditions have only minor
effects on cellular viability [24]. As a control, we incubated cells in
HBS without MCD supplement at 37 ◦C.
2.3. Calcium measurement
All calcium measurements were performed at room tempera-
ture in HBS. Cells were loaded for 30 min  at 37 ◦C with 3 M of either
fura-2/AM of fluo-4/AM (Invitrogen) in HBS supplemented with
0.2% (w/v) bovine serum albumin. Subsequently, cellular choles-
terol content was modulated. After washing the cells with HBS
without MCD or MCD–cholesterol, calcium measurements were
performed.
Concentration response curves were monitored in fluo-4-
loaded cell suspensions. To this end, cell suspensions were
dispensed into 384-well plates and mounted on the stage of
a custom-made fluorescence imaging plate reader [25] built
within a robotic liquid handling station (Freedom Evo 150, Tecan,
Switzerland). Modulators or agonists were applied with the 96-
tip multichannel arm. The image acquisition was  controlled by
the MicroManager software (Version 1.3; US National Institutes
of Health, Bethesda, MD)  [26], and image evaluation was per-
formed with ImageJ (US National Institutes of Health) [27]. Mean
fluorescence intensities of individual wells were determined, cor-
rected for background signals, and normalised to initial intensities
(F/F0). Intensity values at the end of the measurement (2.5 min  after
agonist application) were extracted, and concentration-dependent
effects were parameterised by fitting the data obtained with various
activator concentrations to a four parameter Hill equation:
E = Emin + (Emax − Emin)
1 + ([A]/EC50)−nH
,
where E represents the observed effect, [A] is the concentration of
activator, EC50 the activator concentration yielding a half-maximal
effect, and nH the Hill coefficient.
For single cell calcium measurements, cells were grown on
glass coverslips, loaded with the ratiometric calcium indicator fura-
2/AM, and imaged with an inverted microscope (Fluar 10×/0.5;
Axiovert 100 microscope, Carl Zeiss, Jena, Germany). For excitation
we used a fibre-coupled monochromator device (Polychrome V,
Till-Photonics, Gräfelfing, Germany) at alternating wavelengths of
340, 358, and 380 nm.  Emission was  imaged with a cooled CCD cam-
era (Sensicam, PCO, Kelheim, Germany) through a dichroic beam
splitter (DCXR-510, Chroma, Rockingham, VT) and a 515 nm long-
pass filter (OG515, Schott, Jena, Germany). Fluorescence intensities
were averaged over regions of individual cells. Background
signals were subtracted, and intracellular calcium concentra-
tions where calculated with a spectral fingerprinting method as
described [28].
2.4. Confocal laser scanning microscopy
Cells were imaged using an inverted confocal laser scanning
microscope (LSM510-META, Carl Zeiss AG, Oberkochen, Germany),
with a C-Apochromat 40×/1.2 water immersion objective. CFP-
tagged TRP channels were excited with the 458-nm line of an Ar+
laser, and emission was  detected through a 500/50 nm band-pass
filter.
2.5. Electrophysiological procedures
For the electrophysiological characterisation of TRPV3, HEK293
cells were seeded on poly-l-lysin-coated (0.02%, Sigma–Aldrich)
glass coverslips, and cultured for 24 h. Unless otherwise indicated,
whole-cell recordings were made at room temperature, using an
EPC9 amplifier controlled by the PULSE software (HEKA, Lambrecht,
Germany). The standard extracellular solution contained 140 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM glucose, 10 mM  HEPES and
1 mM CaCl2 (adjusted to pH 7.4 with NaOH, and to 305 mosmol/l
with mannitol). The pipette solution included 110 mM CsCl, 4 mM
MgCl2, 10 mM EGTA and 10 mM HEPES (pH 7.2 with CsOH). For
whole-cell recordings, patch pipettes had a resistance of 3–5 M.
Serial resistances were always less then 10 M and compensated
by 80%. Liquid junction potentials added up to +4.1 mV and were
not compensated in the illustrated figures.
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Fig. 1. Cholesterol enrichment sensitises mTRPV3 to lower agonist concentrations. HEKmTRPV3 cells were loaded with the Ca2+ indicator dye fluo-4, and cellular cholesterol
was  depleted or enriched via incubation in MCD (10 mM)  or MCD–cholesterol (10:1; 2.5 mM)  for 15 min  at 37 ◦C, respectively. After washing with HBS, fluo-4 fluorescence
was  recorded during stimulation with the TRPV3 activators 2-APB (A, n = 7), carvacrol (B, n = 6), and thymol (C, n = 6) applied at the indicated concentrations. Fluorescence
intensities were background-corrected and normalised to the initial fluorescence intensity F0 (left panels). Concentration-dependent increases in F/F0 were fitted to a four
parameter Hill equation (middle panels) and calculated EC50 values are depicted (right panels; *p < 0.05, **p < 0.01, one way ANOVA).
Slow voltage ramps (0.12 mV/ms) ranging from −60 to +60 mV
were applied every 2 s, filtered at 0.3 kHz and sampled with 1 kHz.
Chemical activators were applied with a gravity-driven perfusion
system. Recorded current intensities at −60 and +60 mV  were
normalised to the cell size using the corresponding capacity. To
investigate the heat activation of TRPV3, we used an inline solu-
tion heater (TC-324B, Warner Instruments). The temperature of the
bath solution ranged between 20 ◦C and 40 ◦C, and was  recorded
with a thermistor electrode placed in the vicinity of the patched
cell. Since currents (at Vh = 60 mV)  in untransfected control cells
rose by less than 3.5-fold during the exposure to buffer solutions
heated from 20 ◦C to 40 ◦C, whereas TRPV3-expressing cells exhib-
ited larger increases, we defined the factor of 3.5 as the lower
level of detection (LLD) of current contributions arising from ther-
mal  activation of TRPV3. The corresponding temperature at which
currents exceeded the LLD was termed TLLD. Temperature coeffi-
cients (Q10) were calculated for the temperature ranges of 21–27 ◦C,
28–32 ◦C and 33–39 ◦C, according to:
Q10 =
(
I2
I1
)10/T
,
where I1 and I2 were obtained from Arrhenius plots for a given
temperature increment T  by linear regression analysis.
2.6. Statistical analysis
Results are depicted as means ± S.E.M. To test for statistically
significant differences, we  used the Student’s t-test for two  nor-
mally distributed data groups or the ANOVA test combined with
Tukey’s test for more then two data groups.
3. Results
3.1. Cholesterol enrichment sensitises mTRPV3 to lower agonist
concentrations
TRPV3 channels are differently regulated by physical and chem-
ical stimuli, hence the question arose, if TRPV3 activity is dependent
on the content of cellular cholesterol. To address this question,
we modulated the cholesterol content of fluo-4-loaded HEKmTRPV3
cells, and performed calcium measurements in a plate imaging-
based approach. We  generated concentration response curves with
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Fig. 2. TRPV2 signalling is not affected by modification of cellular cholesterol. Measurements were performed as described in Fig. 1, but with HEK293 expressing TRPV2.
Cells  were activated with 2-APB at different concentrations to generate concentration–response curves. Depicted are single traces of representative normalised fluorescence
time  courses (left panel), aggregated data of several experiments performed with various activator concentrations (middle panel, n = 6), and the calculated EC50 values (right
panel).
the known TRPV3 activators 2-APB, carvacrol and thymol (Fig. 1).
Without manipulating the cholesterol content, the respective EC50
values were in agreement with established literature data [29].
Interestingly, the EC50 of the cholesterol-treated samples sig-
nificantly shifted to lower agonist concentrations compared to
cholesterol-depleted or unmodified HEKmTRPV3 cells. The sensitisa-
tion was observed with all tested TRPV3 activators. Compared with
untreated control cells, the EC50 of 2-APB and thymol to activate
TRPV3 appeared higher in cholesterol-extracted cells, but the dif-
ferences were not statistically significant. The Emax and Hill slopes
nH were not significantly altered between the different approaches
(not shown). On the basis of these results, we conclude that choles-
terol enrichment enhances the sensitivity of HEKmTRPV3 towards all
used TRPV3 activators.
To test if the potentiating effect of cholesterol is a more gen-
eral feature of temperature-activated TRP channels, we  analysed
the influence of cholesterol on rat TRPV2, a closely related and 2-
APB-sensitive member of the TRPV subfamily. In contrast to the
findings with TRPV3, TRPV2 responses to 2-APB were not dis-
cernibly affected by cholesterol modification (Fig. 2).
3.2. Electrophysiological properties of cholesterol-enhanced
mTRPV3 currents
In order to confirm and to quantify the impact of choles-
terol supplementation on TRPV3-mediated cation currents, we
performed whole-cell patch clamp experiments with HEKmTRPV3
cells. After variation of cellular cholesterol content, we  patched
the cells and activated them by adding 30 M 2-APB to the bath
solution. HEKmTRPV3 cells responded with typical outwardly recti-
fying currents that increased during repetitive activation (Fig. 3) [4].
HEKmTRPV3 cells that were incubated in MCD–cholesterol showed
about 6.3-fold and 5.2-fold higher current densities in response to
the initial 2-APB stimulation compared to buffer-treated control
cells at −60 mV  and +60 mV,  respectively. The current facilita-
tion in cholesterol-supplemented HEKmTRPV3 cells during the first
and following pulses of 2-APB stimulation was highly significant
(p < 0.01, ANOVA test). Accordingly, the typical current run-up dur-
ing repetitive activation [30] with a non-saturating concentration
(30 M)  of 2-APB was not observed in cholesterol-supplemented
cells. In the absence of 2-APB, basal current densities in cholesterol-
supplemented cells were slightly smaller compared to untreated
cells (Fig. 3C). The capacity that correlates with cell size and plasma
membrane thickness (Cslow) was significantly decreased by about
20% upon cholesterol enrichment (14.1 ± 0.7 pF in control cells,
11.4 ± 0.8 pF in cholesterol-enriched cells, Student’s t-test p < 0.05).
HEKmTRPV3 cells that were cholesterol-depleted by preincuba-
tion in MCD displayed a trend towards smaller 2-APB-induced
currents, but differences did not reach statistical significance when
compared to the current densities in buffer-treated control cells.
3.3. Temperature-dependent activation of TRPV3 is sensitised by
cholesterol enrichment
To test if thermal activation of TRPV3 is influenced by choles-
terol, we  investigated heat-induced currents in HEKmTRPV3 cells
by electrophysiological patch clamp experiments in the whole-
cell mode. As expected [30], repeated application of temperature
ramps (from 20 ◦C to 38–40 ◦C) resulted in a time-dependent aug-
mentation of outwardly rectifying currents in control HEKmTRPV3
cells. Upon cholesterol supplementation, mean current densities
were significantly increased (two way ANOVA, p < 0.01, Fig. 4A–C).
During the sixth application of buffer heated to 37 ◦C, an about
11-fold and 20-fold augmentation compared to untreated control
HEKmTRPV3 cells was  observed at −60 mV and +60 mV,  respectively.
Since heat-induced gating of thermosensory TRP channels does
not exhibit a sharp threshold temperature at which channel open-
ing begins, shifts of the temperature sensitivity of mTRPV3 were
assessed by measuring the temperature TLLD when currents den-
sities rose in TRPV3-expressing cells increased by more than
3.5-fold – a factor that was not reached in untransfected control
cells (Fig. 4D). At the first two temperature-induced activation
cycles, only 44% of investigated, buffer-treated HEKmTRPV3 cells
showed TRPV3-like currents that met  this criterion, and the TLLD
of responsive cells was  35.8 ± 1.0 ◦C. During the sixth activation
cycle, significant heat-induced currents were observed in about
78% of tested cells, and the TLLD was  36.6 ± 1.1 ◦C. In experiments
with cholesterol-enriched HEKmTRPV3 cells, 72% of investigated cells
showed TRPV3-like currents, and the TLLD of responsive cells was
34.0 ± 1.1 ◦C during the first two  activation cycles. During the third
to sixth temperature cycles, all cells displayed large TRPV3 currents,
and TLLD was  already achieved at 31.1 ± 0.6 ◦C (see Fig. 4D).
Comparisons between buffer-treated and cholesterol-enriched
cells become more sensitive by analysing aggregated data of all
patched cells (n = 9 cells each). In Arrhenius plots (Fig. 5A and B),
significance of temperature sensitisation by cholesterol feeding
was reached at temperatures above 33 ◦C during the third tem-
perature ramp and further shifted to lower temperatures (above
27 ◦C) during the sixth temperature ramp. We therefore defined
temperature ranges of 21–27 ◦C, 28–32 ◦C, and 33–39 ◦C for calcu-
lating Q10 values of temperature-activated TRPV3 currents. During
the third temperature ramp, buffer-treated HEKmTRPV3 cells did not
show discernible increases in Q10 values at temperatures up to 40 ◦C
(Fig. 5C). By contrast, cholesterol-treated HEKmTRPV3 displayed
steeper slopes (see Fig. 5A) and higher Q10 values at tempera-
tures above 28 ◦C (Fig. 5C). During the sixth temperature ramp,
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Fig. 3. Whole-cell patch-clamp recordings of TRPV3 currents in cholesterol-modified HEKmTRPV3 cells. Adherent HEKmTRPV3 cells were incubated in HBS (control) or in HBS
supplemented either with 10 mM MCD, or with 2.5 mM cholesterol-preloaded MCD (MCD–chol.) for 15 min  at 37 ◦C. Subsequently, whole-cell currents were recorded
during  repetitive stimulation with 30 M 2-APB. Data were extracted from repeatedly (every 2 s) applied voltage ramps (−60 to 60 mV; 0.12 mV/ms). (A) Representative
traces  of recorded current densities at −60 and +60 mV.  (B) Current densities during voltage ramps obtained at the time points indicated in (A). (C) Aggregated data of all
cells  measured as shown in (A) (n = 7 each, *p < 0.05, **p < 0.01).
buffer-treated HEKmTRPV3 cells displayed a minor increase in
the Q10 value at temperatures above 32 ◦C, whereas cholesterol-
supplemented HEKmTRPV3 cells yielded about 3-fold higher Q10
values at temperature ranges of 28–32 ◦C and of 33–39 ◦C com-
pared to the buffer-pretreated controls (Fig. 5D). Thus, TRPV3 is
sensitised to lower temperatures and confers markedly higher
current amplitudes at 37 ◦C after cellular cholesterol enrich-
ment.
3.4. Intracellular fraction of TRPV3 is increased by cholesterol
enrichment
To investigate if the cellular localisation of TRPV3 channels is
affected by cholesterol treatment, we modulated cellular choles-
terol, and subsequently monitored the localisation of mTRPV3-CFP
in HEKmTRPV3 cells by confocal laser scanning microscopy. In
buffer-treated cells, mTRPV3-CFP was mostly located at the plasma
membrane (Fig. 6A), and only a minor fraction of the protein was
observed in intracellular compartments, most likely on endomem-
branes. Upon cholesterol extraction with MCD, cell rounding
occurred, but TRPV3 was  still predominantly located in the plasma
membrane and to a small extent in intracellular compartments.
By contrast, cholesterol enrichment led to an enhancement of
the intracellular fraction of TRPV3-CFP. HEK293 cells expressing
TRPV2-CFP showed a similar shift of localisation by cholesterol
modulation (Fig. 6B). Thus, the potentiating effect of cholesterol
on TRPV3 currents cannot be attributed to an enhanced surface
localisation.
3.5. Calcium responses to TRPV3 activators are increased in
HaCaT keratinocytes endogenously expressing TRPV3
The human keratinocyte cell line HaCaT, like primary ker-
atinocytes, expresses TRPV3 [20,21]. To investigate if cholesterol
modifies human TRPV3 channel activity in a system that natively
expresses TRPV3, single cell calcium measurements with HaCaT
keratinocytes were carried out. These cells showed more sponta-
neous calcium signals when cholesterol-enrichment occurred at
37 ◦C. We  therefore chose conditions with 5 mM MCD–cholesterol
in HBS and room temperature for more gentle enrichment. Choles-
terol supplementation resulted in a more than 2-fold enhancement
of [Ca2+]i increases upon stimulation with the TRPV3 activators car-
vacrol (500 M)  and camphor (10 mM)  (Fig. 7; p < 0.05, two way
ANOVA). We  therefore conclude that cholesterol also potentiates
the activity of TRPV3 natively expressed in HaCaT keratinocytes.
4. Discussion
In the present study, we showed for the first time an enhanced
TRPV3 activity as a result of cellular cholesterol supplementa-
tion. Applying [Ca2+]i analyses and patch clamp experiments,
we found that cholesterol enrichment led to a robust increase
in TRPV3 sensitivity to chemical and physical modes of TRPV3
activation. Cholesterol enrichment shifted the concentration
dependence of TRPV3 to lower activator concentrations, and low-
ered the temperature at which TRPV3 currents became detectable
in TRPV3-expressing cells. Similarly, cholesterol-supplemented
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Fig. 4. Cholesterol enrichment strongly potentiates heat-induced TRPV3 currents. After modification of cellular cholesterol in HEKmTRPV3 cells, whole-cell currents were
recorded during repeated activation of TRPV3 by temperature ramps from 20 ◦C to 40 ◦C. (A) Typical time course of currents at −60 and +60 mV in an untransfected parental
HEK293 cell (grey line), in a buffer-treated HEKmTRPV3 cell (black line; left panel), and in a cholesterol-enriched HEKmTRPV3 cell (right panel). Note the different scaling of
the  panels. (B) Current voltage traces recorded in a buffer-treated HEKmTRPV3 cell (left panel), and in a cholesterol-enriched HEKmTRPV3 cell (right panel). Data correspond to
the  time points indicated in (A). (C) Statistical analysis of temperature-induced current densities measured at 37 ◦C during the rising phase of the temperature ramps. (D)
Lowest temperatures at which TRPV3-related currents became evident (TLLD) in temperature ramp experiments performed as shown in (A). (C and D) Results depict means
and  S.E.M. of n = 9 patched cells for each condition during six consecutive applications of temperature ramps (*p < 0.05, **p < 0.01).
HaCaT keratinocytes exhibited higher [Ca2+]i increases in response
to different TRPV3 activators.
TRPV3-induced currents observed in cholesterol-enriched
HEKmTRPV3 cells exhibited typical features of TRPV3, including
outward rectification and sensitisation by repeated activation.
Cholesterol supplementation of HEKmTRPV3 already gave rise to
strongly increased current densities during the first activation
cycle. During repeated challenging with 2-APB, TRPV3 currents
then exhibited no further run-up, indicating that 30 M 2-APB rep-
resent a saturating activator concentration under these conditions,
whereas higher 2-APB concentrations or repeated activation cycles
are required in untreated HEKmTRPV3 cells to obtain full activation
of TRPV3. Since we neither found increases in basal [Ca2+]i nor
recorded augmented basal current densities in the absence of a
chemical activator in cholesterol-enriched HEKmTRPV3 cells, choles-
terol itself does not appear to activate TRPV3 at room temperature.
Considering that the skin temperature in vivo is typically lower
than the values that are required to trigger TRPV3 activation in a
recombinant setting, the cholesterol-induced shift of the thermal
sensitivity of TRPV3 to lower temperatures may provide a mecha-
nistic basis for TRPV3 regulation by physiological temperatures in
the skin.
To pursue the matter if cholesterol-dependent potentiation
is a common feature of temperature-activated TRPV channels,
we examined TRPV2-mediated responses to 2-APB stimulation in
cholesterol-modified HEK293 cells. In our hands, there was  no
influence of cholesterol on TRPV2 signalling. The role of cholesterol
in the regulation of TRPV1, the best characterised, heat-activated
member of the TRP family has intensively been investigated in
different studies, but the documented effects are controversial.
Cholesterol enrichment led to an increased activation temperature
in rat TRPV1-expressing HEK293 cells [31], and, in another study,
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Fig. 5. Temperature dependence and Q10 values of heat-induced currents measured in cholesterol-enriched HEKmTRPV3 cells. Current densities at +60 mV recorded as shown
in  Fig. 4 during the rising phases of temperature ramps were normalised to current densities measured at 25 ◦C, and plotted against the actual temperature during the 3rd
(A)  or 6th (B) temperature ramp. Current densities were averaged over 1-◦C temperature steps. Data represent mean current densities of n = 9 cells. Slopes of temperature-
correlated increases in current densities were calculated by linear regression analysis for temperature ranges of 21–27 ◦C, 28–32 ◦C, and 33–39 ◦C, respectively. (C and D) Q10
values of TRPV3-induced currents were calculated for the temperature ranges described in (A) and (B).
Fig. 6. Cellular localisation of heterologously expressed mTRPV3-CFP. Living HEK293 cells expressing TRPV3-CFP (A) or TRPV2-CFP (B) were imaged after cholesterol depletion
(left  panels), without cholesterol modification (middle panels), or after cholesterol supplementation (right panels). Upper panels: Nomarski differential contrast (DIC) images;
lower  panels: confocal laser scanning microscope images (scale bar: 25 m).
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Fig. 7. Activation of TRPV3 in cholesterol-modified HaCaT cells. HaCaT cells were loaded with the calcium indicator fura-2 and incubated for 15 min at room temperature in HBS
(control) or in HBS supplemented with 5 mM MCD–cholesterol. Subsequently, calcium responses to repeatedly applied carvacrol (A) or camphor (B) were monitored. Shown
are  responses in single cells (grey lines) and the averaged signal (black line) of representative measurements. (C and D) Aggregated analysis of experiments performed as shown
in  (A) and (B), calculated from 4 (carvacrol stimulation) and 12 (camphor stimulation) independent [Ca2+]i imaging experiments performed in buffer- or cholesterol-treated
HEKmTRPV3 cells, each. Shown are basal [Ca2+]i values immediately before agonist application and peak concentrations during the first application of the agonist.
decreased capsaicin-induced TRPV1 currents [32]. On the other
side, cholesterol depletion inhibits the formation of large TRPV1
pores evoked by prolonged activation of TRPV1 in CHO cells [33].
Similarly, cholesterol extraction diminishes the TRPV1 response
to capsaicin and resiniferatoxin (RTX) stimulation in trigeminal
neurons [34], and to capsaicin and acidification in DRG neurons
[35], but in transfected CHO cells, only the capsaicin response
was reduced and stimulation with RTX or low pH was not influ-
enced by MCD [34]. In other studies, cholesterol depletion did not
significantly change TRPV1 activation properties [31,33]. TRPM3
channels, recently shown to be warm sensitive [36], are inhibited by
cholesterol supplementation [37]. The cold sensing member of TRP
channels, TRPM8, however, is potentiated by cholesterol depletion
[38,39]. Thus, cholesterol-mediated potentiation seems not to be a
common hallmark of temperature-activated TRP channels, hinting
to a specific physiological importance of the cholesterol-enhanced
TRPV3 signalling.
Different mechanisms of the impact of cholesterol on TRP chan-
nel activity are conceivable. Cholesterol may  indirectly affect TRP
channels by promoting the interaction with intracellular signal
cascades. For instance, TRPC6 has been shown to be sensitised
to mechanical activation by a cholesterol-mediated binding of
podocin [40]. TRPV3 signalling is facilitated by EGF receptor stimu-
lation [16]. Indeed, the EGF receptor activity is regulated by plasma
membrane cholesterol, but several studies have demonstrated that
cholesterol depletion led to autoactivation of EGF receptors and its
activity is rather abrogated by cholesterol supplementation [41].
Another possibility is the phospholipase C-mediated TRPV3 poten-
tiation [11,16]. Cholesterol loading may  lead to phospholipase C
activation [42] resulting in a decreased level of PIP2 at the plasma
membrane, a lipid known to inhibit TRPV3 activity [11]. Applying
the cholesterol supplementation protocol used in the actual study,
we found no significant activation of phospholipase C, as monitored
in living cells by observing the plasma membrane translocation
of PKC-YFP, a diacylglycerol-sensitive fluorescent biosensor pro-
tein [43] (data not shown). In addition, PIP2 depletion would also
facilitate TRPV2 desensitisation [44], but we noticed no enhanced
desensitisation of TRPV2-mediated calcium signals in cholesterol-
enriched cells.
Another possibility of indirect modulation may  involve the
plasma membrane targeting of TRPV3. Cholesterol depletion has
been demonstrated to reduce the plasma membrane fraction of
TRPV1 in DRG neurons, leading to diminished functional activity in
these cells [35]. Studies with TRPM8 showed that cholesterol deple-
tion potentiates TRPM8 activity by shifting its localisation between
raft and non-rafts regions and thereby causes different glycosyla-
tion patterns that in turn influence its temperature and menthol
sensitivity [38]. In addition, cholesterol depletion has been shown
to enhance TRPM8 signals by increasing the number of channels
located in the plasma membrane, an effect that closely resem-
bles our observations concerning the cellular localisation of TRPV2
and TRPV3. The authors suggested that a decreased rate of endo-
cytosis is responsible for the accumulation of TRPM8 channels in
cholesterol-extracted plasma membranes [39].
Since various protein domains are known to interact with
cholesterol, a direct binding to the channel protein may  account
for its functional modulation. Rat TRPV1 has been reported to
contain a cholesterol-binding domain in its S5 helix [32]. The
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homologous region in TRPV3, however, more closely resembles
that of the cholesterol-independent human TRPV1 ortholog [32].
Thus, other motifs or non-linear binding epitopes may  serve the
binding site for cholesterol in TRPV3. At present, we  cannot dis-
criminate between direct interaction and membrane perturbation
as the mechanism of TRPV3 sensitisation by cholesterol.
Cholesterol strongly affects the biophysical properties of lipid
membranes, including their rigidity, fluidity, and thickness. Since
voltage sensitivity and temperature detection of temperature-
sensing TRP channels are highly intertwined and require only
minute movement of their gating charge within the electrical field
of the membrane [45,46], it is obvious that subtle changes in their
membrane environment may  suffice to strongly affect the gating
behaviour. Indeed, the sensitisation to lower temperatures indi-
cates that TRPV3 modulation by cholesterol critically involves the
voltage-sensing mechanism of the channel protein. An allosteric
mechanism of cholesterol bound to moieties of the channel that
are not exposed to the electrical field cannot formally be excluded.
However, a more simple explanation would be that cholesterol-
induced changes of biophysical properties of lipid membranes,
including their fluidity and thickness or cholesterol binding to
TRPV3 within the electrical field facilitate the gating of the channel
by shifting its voltage dependence towards physiological poten-
tials.
TRPV3 is expressed in different cell types, but exerts an
outstanding role in keratinocytes. Recent data of Cheng et al.
demonstrated that TRPV3-deficient mice have curly hair and an
impaired skin barrier formation [16]. These mice exhibited an
increase in the thickness of keratin-1- and keratin-10-positive
epidermal layers, as well as a diminished number of cornified
envelopes, indicating that TRPV3 is critical for the progres-
sion of late differentiation processes [16]. During differentiation,
keratinocytes actively synthesise and accumulate lipids like
ceramides, cholesterol and fatty acids. These lipids are stored in
granules, which are released into the extracellular space in the
upper epidermal layers, where they prevent transepidermal water
loss. A growing body of evidence suggests that cholesterol plays
an important role in differentiation control and induction of the
cornification [47–49]. Thus, future work will be directed to solve
the question whether the increased cholesterol content in dif-
ferentiating keratinocytes and upper epidermal layers, via TRPV3
sensitisation and Ca2+ entry contribute to late keratinocyte differ-
entiation. Of note, TRPV4 is a second heat-activated TRP channel in
keratinocytes, which participates in epidermal barrier formation by
stabilising cell–cell junctions [50]. It may  be interesting to inves-
tigate whether cholesterol also enhances TRPV4 activity and, thus,
possibly supports skin integrity via a second mechanism.
The functional interaction between cholesterol and TRPV3 may
also explain some pathophysiological effects. It is established, that
gain-of-function variants of TRPV3 are involved in the development
of pruritus and hyperkeratosis [17–19] associated with inflamma-
tory skin disorders like atopic dermatitis or with psoriasis. Thus,
functional modulation of TRPV3 channel activity may  provide a
target for pharmacological intervention not only with respect to
nociception, but also to control keratinocyte functions in skin dis-
orders [51].
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The major task of keratinocytes is to protect the organism against harmful external influences. Thus,
they compose a complex outer barrier, the epidermis, where cell proliferation, differentiation, and mi-
gration of keratinocytes are of fundamental significance. In cooperation with neurons, keratinocytes
also play pivotal roles in recognising environmental factors. Amongst other receptors and ion chan-
nels, keratinocytes express temperature-sensitive TRPV3 channels [34,35], whose role in keratinocyte
physiology and pathophysiology is still poorly understood.
Cholesterol is an important lipid for epidermal development. Maturing keratinocytes actively synthe-
sise and accumulate cholesterol and other lipids that are enriched in upper epidermal layers with the
objective to maintain a barrier impermeable to water [7,9]. Moreover, cholesterol chiefly influences
physical properties of membranes like thickness and viscosity [1,2]. It is also known to participate
in several signalling pathways, either by direct interaction or indirectly via recruiting and clustering
transmembrane or membrane-associated proteins.
4.1 HaCaT keratinocytes exhibit a cholesterol and plasma
membrane viscosity gradient during directed migration
During the reepithelialisation phase of wound healing, keratinocytes migrate in cell assemblies. Cells
at the edge adopt a polarised morphology characterised by extended lamellipodia at their front, while
their rears remain in contact with adjacent cells [20,21]. For years, the involvement of signalling lipids
like phosphatidylinositols in cell migration as well as their distribution in the plasma membrane of
migrating cells has intensively been investigated [22]. However, the influence of cholesterol on the
migration capacity of keratinocytes is less well understood. Furthermore, the importance of local
differences of physical membrane properties of polarised keratinocytes has been neglected. Thus, we
analysed the plasma membrane consistency and cholesterol content of keratinocyte-like HaCaT cells
with pronounced lamellipodia at the edge of larger cell assemblies. These cells strongly resemble
keratinocytes at a wound’s leading edge.
4.1.1 Results
• We performed FRAP measurements of FAST DiO-stained HaCaT cells under TIR illumina-
tion [80]. This fluorophore homogeneously labels the plasma membrane in living cells. The
diffusion coefficients of FAST DiO measured at the lamellipodia of polarised HaCaT cells
were significantly higher than those at the cell rears, indicating a plasma membrane viscosity
front-to-back gradient in these keratinocytes with a lower viscosity at their lamellipodia.
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• The fluorescence lifetime of NBD depends on the physicochemical properties of its environ-
ment [81]. Using fluorescence lifetime measurements of HaCaT cells that were labelled with
phosphatidylcholine carrying the NBD group on one acyl chain (NBD-PC) and that were ex-
cited under TIR conditions, we verified the results of the above described FRAP experiment. In
addition, spatially resolved fluorescence lifetime images of NBD-PC-stained HaCaT cells were
obtained for a direct visualisation of this gradient.
• Fixed HaCaT cells that were stained with the cholesterol-binding, fluorescent dye filipin [82],
were analysed by confocal laser scanning microscopy (CLSM). The polarised cells showed a
weaker filipin staining intensity at their lamellipodia when compared with their cell bodies.
• Exposure to epidermal growth factor (EGF) accelerates keratinocyte migration [20,83] in wound
healing models. Applying FRAP and scratch assays, we found a bell-shaped dependence of cell
migration and viscosity gradients on EGF concentrations. Of note, optimal EGF concentrations
with regard to migration speed closely correlated with the most pronounced front-to-back
viscosity gradients in plasma membranes of HaCaT cells.
• EGF supplementation led to an overall increase in plasma membrane viscosity and cholesterol
content. This finding is in agreement with a previous report [84].
• The cholesterol transporter ABCA1 can alter the cholesterol content in the plasma mem-
brane [85]. We investigated the impact of ABCA1 and ABCG1, two cholesterol transporters
expressed in HaCaT cells [86], on the observed gradient. Pharmacological inhibition as well as
small interference RNA-mediated gene silencing of these transporters indicated that ABCA1
but not ABCG1 is responsible for the formation or maintenance of the viscosity gradient in
migrating HaCaT keratinocytes.
4.1.2 Condensed discussion
This study demonstrates that the polarisation of HaCaT keratinocytes is accompanied by the devel-
opment of a microviscosity gradient in their plasma membranes, with a low viscosity observable at
the lamellipodia. An inhomogeneous cholesterol distribution presumably contributes to this gradient,
but further molecules may account for differences of the plasma membrane viscosity. Our findings
underline the importance of cholesterol for keratinocyte migration and indicate that the local choles-
terol distribution is strictly regulated in these cells. It is still an open question whether the membrane
viscosity or rather distinct cholesterol contents are crucial for migrating keratinocytes. Since oppo-
site viscosity and cholesterol gradients have been monitored in the plasma membrane of migrating
endothelial cells [23], it is likely that viscosities optimal for cell migration are cell type-specific.
To identify mechanisms that induce or maintain the microviscosity gradient in migrating keratino-
cytes, we focused on the two cholesterol transporters ABCA1 and ABCG1. They are known to be
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involved in macrophage migration via regulation of Rac1 [6,87], a monomeric GTPase participating in
lamellipodia formation. Reduced ABCA1 activity led to a less pronounced microviscosity gradient in
HaCaT cells, thus, indicating that this transporter affects the development of the cholesterol gradient.
ABCA1 is presumably involved in the translocation of cholesterol from raft to non-raft regions [88], a
fact that may imply a considerable importance of non-raft cholesterol for the microviscosity gradient.
The physiological relevance of the microviscosity gradient may lay in the regional regulation of
signalling pathways. Diverse determinants of keratinocyte physiology are known to be modulated
by cholesterol, including certain components of the cytoskeleton [89], of growth factor signalling
cascades [90], and ion channels [73–79].
4.2 Cholesterol sensitises the transient receptor potential channel
TRPV3 to lower temperatures and activator concentrations
Keratinocytes sense environmental changes via different receptors and ion channels like heat-sensitive
TRPV3 channels. Regulation of TRPV3 channel activity is complex and only incompletely under-
stood [37]. Since TRPV3 dysfunctions are known to favour the appearance of skin diseases [57–63],
there is an increasing need for applicable, pharmacological modulators of this channel [50,57]. Whereas
it has been established that cholesterol affects signalling events mediated by several temperature-
regulated TRP channels [73–78], no such results have been provided regarding the activity of TRPV3.
Hence, we investigated the cholesterol dependence of TRPV3 channel activation by chemical and
thermal stimuli.
4.2.1 Results
• We modified the cholesterol content of HEK293 cells that stably expressed CFP-tagged mouse
TRPV3 (HEKmTRPV3) by subjecting these cells to methyl-b-cyclodextrin (MbCD) or MbCD
preloaded with cholesterol [91]. Subsequently, we analysed the localisation of TRPV3 in these
cells via CLSM. In buffer-treated and cholesterol-depleted cells, TRPV3 channels were mostly
located at the plasma membrane. By contrast, cholesterol enrichment led to an intracellular
accumulation of TRPV3-CFP and a lower number of channels at the plasma membrane.
• Multiwell-based [Ca2+]i measurements in HEKmTRPV3 cells revealed that cholesterol extraction
does not strongly change the sensitivity of TRPV3 towards the chemical activators 2-APB, car-
vacrol and thymol. In contrast, after cholesterol enrichment, significantly lower concentrations
of the aforementioned TRPV3 activators sufficed to stimulate TRPV3-mediated Ca2+ influx.
• Carrying out the same assay, we showed that the response of the closely related channel TRPV2
to stimulation with 2-APB [67] could not be altered by cholesterol enrichment or depletion.
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• The potentiation of TRPV3 responses by cholesterol enrichment was verified in electrophysio-
logical whole-cell patch clamp experiments. Considerably larger TRPV3 currents were evoked
in cholesterol-enriched cells by 2-APB application when compared with HEKmTRPV3 cells that
were not supplemented with cholesterol. By contrast, no significant differences could be ob-
served when comparing currents evoked in cholesterol-depleted cells and untreated controls.
• Patch clamp experiments showed that currents induced by temperature increases were robustly
amplified in cholesterol-fed HEKmTRPV3 cells. Under these conditions, temperature thresholds
for TRPV3 activation were lowered by approximately 5°C, and currents revealed considerably
higher 10-degree temperature coefficients (Q10 values).
• We also tested the response of HaCaT keratinocytes [42] natively expressing TRPV3 [43,44].
HaCaT keratinocytes displayed increases in [Ca2+]i upon the application of carvacrol or cam-
phor. These responses could be augmented by cholesterol supplementation.
4.2.2 Condensed discussion
Based on our previous findings indicating that keratinocytes strongly regulate the cholesterol con-
tent of their plasma membranes, we investigated the cholesterol dependence of TRPV3 function, a
temperature-regulated ion channel expressed in these cells. Our results demonstrate that cholesterol
enrichment strongly increases TRPV3 channel activity. Hence, it may be speculated that cholesterol
serves as an endogenous modulator of TRPV3. However, the exact mechanism by which cholesterol
affects these channels is still unknown. We could exclude an enhanced surface targeting of TRPV3
channels as a result of cholesterol supplementation, but a cholesterol-dependent lateral reorganisation
within the plasma membrane possibly facilitates TRPV3 signalling. The possibility that cholesterol
indirectly influences TRPV3 activity by interacting with other signalling cascades should also be con-
sidered. Alternatively, TRPV3 may directly bind cholesterol, as has been proposed for TRPV1 [77].
Although the TRPV3 sequence does not feature the same cholesterol-binding motif as TRPV1, other,
perhaps non-linear cholesterol-binding domains may exist in TRPV3. Since many TRP channels re-
spond to physical stimuli, such as temperature changes or plasma membrane depolarisation [64,65],
cholesterol-dependent modulation of TRPV3 may rely on complex physical processes.
Investigations of Cheng et al. indicate that TRPV3 is crucial for the progression of late differentiation
processes of keratinocytes [13]. Our findings support the hypothesis that the increased cholesterol
content in differentiating keratinocytes and the upper epidermal layer [9,10] results in a sensitisation
of TRPV3, whose enhanced signalling is necessary to promote late keratinocyte differentiation. A
growing body of evidence suggests that gain-of-function mutations in TRPV3 play a role in the
development of skin disorders like the Olmsted syndrome [57–63]. A better understanding of TRPV3
regulation may pave the way towards an efficient treatment of this skin disease.
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Methods
Quantification of cellular cholesterol content
Cholesterol was quantified using a cholesterol quantification kit (R-Biopharm AG, Darm-
stadt, Germany), following the manufacturers instructions with minor modifications.
This technique is based on enzymatic oxidation of cholesterol, which results in an in-
crease in absorbance at 405 nm. After starving HaCaT cells for 24 h, they were grown
for 12 h in the presence or absence of EGF in serum-free medium under cell culture
conditions. After detaching the cells with trypsin, cells where counted using a hemocy-
tometer and centrifuged. The cell pellet (about 5–10 · 105 cells) was collected in 15 µl
isopropanol and vortexed. The volumes of the used solutions were adapted onto a 384-
well format. Absorbance was measured with a multiwell plate reader (Polarstar Omega,
BMG Labtech, Offenburg, Germany). The cholesterol content was normalised to the cell
count.
Reverse transcription-polymerase chain reaction
About 2 · 105 HaCaT cells were seeded in 35-mm cell culture dishes and transfected
with siRNA and DNA for cytosolic GFP to evaluate the transfection efficiency. 24
or 48 h after transfection, total RNA was isolated (GeneJET, Fermentas, St. Leon-
Rot, Germany) and reverse transcribed via random hexamer primer (SuperScript II,
Invitrogen). Subsequently, the mRNA of ABC transporters and GAPDH, as an internal
control, were amplified (GoTaq, Promega, Mannheim, Germany) with specific primers
(Supplementary table 1). After denaturation for 2 min at 95 multiple PCR cycles
proceeded consisting of 30 s at 95, 30 s at 50 for GAPDH, 60 for ABCA1 or 65
for ABCG1 followed by 30 s at 72. GAPDH mRNA was amplified by 23 cycles, ABCA1
mRNA and ABCG1 mRNA by 35 cycles.
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5’  3’ product size (bp)
hABCA1 [1] for. GCACTGAGGAAGATGCTGAAA 205
rev. AGTTCCTGGAAGGTCTTGTTCAC
hABCG1 [1] for. CAGTGACAGCCATCCCGGTGCT 252
rev. CGATGAAGTCCAGGTACAGCTTGGC
hGAPDH for. CTCATTTCCTGGTATGAC 277
rev. GAGCACAGGGTACTTTAT
Supplementary table 1: Primers used for RT-PCR.
hABCA1 HSS176437 CACUUCCUCCGAGUCAAGAAGUUAA
HSS176438 GCCUUGGCAGUGUCCAGCAUCUAAA
HSS176439 GACCAAAGUGAUGAUGACCACUUAA
hABCG1 HSS145231 UCGUCCAUGGAAGGCUGCCACAGCU
HSS145233 UCUCGCUGAUGAAAGGGCUCGCUCA
HSS190466 CAUAUUUGAGGGAUUUGGGUCUGAA
Supplementary table 2: siRNAs used for specific knockdown of ABCA1 or ABCG1.
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Figures
Supplementary figure 1: Short and intermediate lifetimes of NBD in NBD-PC-stained
polarised HaCaT cells under TIR excitation. Evaluation of the fluorescence decay of
NBD revealed three separate lifetimes, the longest lifetime being strongly dependent on
lipid-induced physical properties of membranes. The shortest (a) and intermediate (b)
lifetimes of NBD measured at the front of polarised HaCaT keratinocytes did not di-
verge statistically significantly from the values measured at the back of the cells (p> 0.05,
mean±SEM, the results of individual cells are depicted in gray). The shortest fluores-
cence lifetimes τ1 measured at the fronts and rears of NBD-PC-stained HaCaT cells were
0.30± 0.02 ns and 0.28± 0.02 ns, respectively. The intermediate fluorescence lifetimes τ2
were 2.17± 0.06 ns at the front and 2.23± 0.07 ns at the rear of HaCaT cells.
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Supplementary figure 2: The cellular cholesterol content is elevated in HaCaT cells grown
in the presence of EGF compared with starving cells. HaCaT were cultured for 12 h
in media containing none or 10 ng/ml EGF followed by the determination of cellular
cholesterol content that was normalised to the cell count (n = 8, unpaired Student’s t-
test # p< 0.05).
Supplementary figure 3: HaCaT keratinocytes adjacent to leading cells at the edge of a
cell assembly do not possess a plasma membrane microviscosity gradient like polarised
leading cells. a: Diffusion coefficients determined by a FRAP approach in polarised
HaCaT cells that were stimulated by 10 ng/ml EGF at the edge of a cell assembly and
at adjacent cells behind the leading cells (n = 23; mean±SEM; paired Student’s t-test
** p< 0.008). b: Example of a FRAP experiment on a polarised HaCaT cell and of a
neighbouring cell behind the edge. White points mark the bleach regions, empty arrow
heads indicate the fronts, filled arrow heads the rears of the cells (scale bar: 25 µm).
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Supplementary figure 4: Benzamil and verapamil, inhibitors of ABCG1 and ABCB1,
did not influence the microviscosity gradient in polarised HaCaT cells. Prior to FRAP
experiments, we inhibited ABCG1 with 20 µM benzamil (a) and ABCB1 with 20 µM
verapamil (b) in the presence of 10 ng/ml EGF for 12 h. Polarised HaCaT keratinocytes
still exhibit a microviscosity gradient in the presence of ABCG1 or ABCB1 inhibitors
(n = 24; mean±SEM; paired Student’s t-test * p< 0.05).
Supplementary figure 5: siRNA-mediated knockdown of ABCA1 and ABCG1 in HaCaT
cells. HaCaT were transfected with siRNA against ABCA1 (a) and ABCG1 (b). 24
or 48 h after transfection, total RNA was isolated and mRNA of ABCA1, ABCG1
and GAPDH, as loading control, were reversely transcribed, and amplified with specific
primers. ABCA1 and ABCG1 mRNA was most efficiently downregulated after 24 h
using 25 nM siRNA. c: Transfection effciency was tested by cotransfecting HaCaT with
cytosolic GFP, revealing a transfection efficiency of about 30–50 % (scale bar: 100 µm).
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